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Abstract 
 
The photophysical and photochemical measurements have been made 
on 3 series of novel alpha octa(alkyl-substituted) phthalocyanines. 
Each series is defined by the distinct non-metal or metal ion centre, 
silicon hydroxide, zinc(II) and palladium(II). It is well documented 
that the phthalocyanine molecule possesses several distinct properties, 
including absorption in the red, low fluorescence and high triplet 
quantum yields that make it an ideal candidate as a potential 
photosensitiser in photodynamic therapy. Photodynamic therapy is an 
alternative treatment to cancer using a photosensitiser, which is 
preferentially absorbed by malignant cells and remains dormant until 
activated by red light. This results in the formation of singlet delta 
oxygen via the excited state of the photosensitiser. The generation of 
singlet oxygen leads to cell death.  
 
Fluorescence quantum yields and lifetimes, triplet quantum yields, 
lifetimes and energies and singlet delta oxygen quantum yields were 
measured in 1% v/v pyridine in toluene. The effects of alkyl 
substitution, with increasing chain length, variation of metal ion centre 
and the core modification of the phthalocyanine unit are investigated 
and compared relative to the unsubstituted parent molecules, SiPc, 
ZnPc and PdPc. 
 
All substituted phthalocyanines exhibited a typical phthalocyanine 
absorption spectrum with significant red-shift of the Q-band maxima. 
Q-band maxima for all compounds ranged between 660 – 712 nm and 
extinction coefficients of the Q-band between 10-4 – 10-5 M-1 cm-1. All 
compounds also exhibited triplet quantum yields in the range 0.52 – 
 iii  
0.96 and singlet delta oxygen quantum yields of 0.49 – 0.94, 
illustrating promising photophysical and photochemical properties for 
photodynamic therapy. 
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1. Introduction 
1.1 Cancer 
According to statistics published by Cancer Research UK, every two 
minutes someone is diagnosed with cancer. Cancer, medically termed 
malignant neoplasm, is the rapid and uncontrolled division of cells, 
which form malignant tumours that have the potential to spread 
further a field from the site of origin, via the bloodstream and 
lymphatic system, to infect other organs.1 The word cancer is derived 
from the Greek carcinos referring to the crab like appearance of a 
solid malignant tumour.2-4 While there is a vast range to the degree 
and severity of the disease Cancer Research UK showed that 1 in 3 
people will get cancer in their lifetime.5 With this in mind, research is 
ongoing to identify the key causes of cancer in order to prevent the 
disease, whether through medically advanced gene therapy or, more 
simply, through changes in diet and lifestyle. Nevertheless, the high 
instance of cancer diagnosis suggests that developing efficient and 
successful treatments is also a major priority. 
 
Depending on the source, severity and spread of the disease there are 
three main approaches used to reduce and remove a tumour. Surgery 
is often the primary option when the tumour is on tissue, organs or 
nodes that can be removed with little disruption to vital organs within 
the body. This treatment comes with all of the risks and side-effects of 
standard surgery, including a risk of death, paralysis and infection.1 
 
If the tumour is too large to remove and needs to be reduced first then 
chemotherapy may be the route of choice. Chemotherapy is a 
1.1 Cancer 
 2 
chemical approach to the treatment of cancer and is often the 
combination of two or more drugs from a catalogue of 50 clinically 
tested compounds.6 The treatment affects both cancerous and normal 
cells, though healthy cells have the ability to repair the damage caused 
by chemotherapy whereas malignant cells cannot. As a consequence, 
many of the side-effects are related to areas that have a high cell 
turnover, such as the mouth, bone marrow and the digestive system. 
Common side effects include increased risk of infection, anaemia, 
bleeding and bruising, hair loss, nausea and vomiting, diarrhoea and 
constipation, change of taste and an increased risk of secondary 
cancers. 
 
Radiotherapy is the third option often used to cure cancer or reduce 
the chances of cancer returning.1 This technique uses a radioactive 
source, either internally or externally, to destroy cancer cells within 
the affected area. However, as with chemotherapy, it is a 
non-discriminatory treatment and so normal cells are susceptible to 
damage, though, it is thought they have the mechanism to self-repair. 
The common side-effects include fatigue, nausea, loss of appetite, sore 
skin, sensitivity to the sun, hair loss and more long-term effects such 
as infertility and a risk of secondary cancers. 
 
With the severe side-effects associated with these treatments and a 
combined vulnerability of the patients involved, research is moving 
forward to find alternative non-invasive therapies with reduced side-
effects. With this in mind there has been the emergence of hormonal 
therapies, biological therapies and investigations into phototherapy. 
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A promising alternative to chemotherapy and radiotherapy is the use 
of chemical agents in combination with light; this is known as 
photodynamic therapy (PDT). However, unlike chemotherapy, the 
chemicals administered are preferentially absorbed by cancerous cells 
where they remain dormant until activated with targeted light of 
specified wavelength. These chemicals are called photosensitisers. 
Once the photosensitiser is activated it forms excited states that 
interact with the molecular oxygen present in the cells to generate 
singlet delta oxygen, the cytotoxic agent responsible for cell death. 
 
There are many benefits to PDT over standard techniques including 
efficiency, ease of use and low costs.7, 8 However, the key advantage 
in terms of patient care is the minimisation of harmful side-effects. 
The very nature of the technique with preferential absorption of a 
dormant photosensitiser coupled with targeted light delivery produces 
a highly selective and non-invasive treatment thereby limiting the 
damage to surrounding healthy tissue. This means PDT does not yield 
the same threat of secondary cancers as demonstrated with other 
techniques. The only significant side-effect appears to be a heightened 
sensitivity to light post-treatment, which remains until the 
photosensitiser has cleared the system. With current photosensitisers 
this may take up to 10 weeks.9 
1.2 Light Therapies from Ancient Civilizations to the 
Modern World 
Light as a form of therapy is repeatedly referred to throughout history 
and across the globe. It has been most widely used in the treatment of 
a variety of commonly occurring ailments. The Ancient Greeks are 
documented as employing whole-body sun exposure to treat a variety 
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of ailments. In fact, the famous Greek physician, Herodotus, is 
recorded as emphasising the importance of sunlight for health and 
coining the term heliotherapy. There was particular emphasis placed 
on the importance of light in restoring the entire body to health.10 
 
In eighteenth and nineteenth century France, sunlight was commonly 
used in the treatment of a number of conditions including, tuberculosis, 
rickets, scurvy, rheumatism, paralysis and oedema.11 In 1815, Carvin 
documented the curing effects of sunlight on rheumatism, scurvy, 
paralysis and muscle weakness.12 In 1822, Sniadecki, a Polish 
physician, wrote of the importance of sun exposure for the prevention 
of rickets.13 
 
In 1903, Danish scientist Niels Ryberg Finsen was awarded one of the 
first Nobel Prizes in Medicine for his work on the treatment of facial 
sores of patients suffering from tuberculosis. His research 
demonstrated the impact of ultraviolet light, using carbon arc 
phototherapy, in treating these lesions and brought to the attention of 
the modern world the potential of light in medicine. For this he is 
often referred to as the father of modern light therapy.14 
 
In today’s world we are increasingly aware of the dangers of over 
exposure to sunlight and, in particular, ultraviolet radiation. However, 
it is important to recognize two biological processes in which light 
plays a significant role. The first process is one alluded to throughout 
history, which is the treatment of rickets.9 Rickets is a bone 
deformation as a result of insufficient calcium uptake. This in turn is 
due to insufficient production of vitamin D within the body. During 
the reign of the British Empire it was noticed that there were huge 
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differences in the number of people suffering from rickets in Victorian 
Britain, where it was a common ailment, compared with those in India, 
where it was virtually unheard of. It is now understood that this is due 
to the different degrees of exposure to sunlight in the two locations.9 It 
was shown that Vitamin D is synthesised within the body through 
biological processes that are stimulated by the absorption of 
ultraviolet light.15, 16 
 
The second significant case of light therapy was discovered in the 
1950s by Dr. Richard Cremer and the acute observations of his 
neonatal nurse Sister J Ward.17 This is the treatment of neonatal 
hypobilirubinaemia, otherwise known as jaundice. The discovery that 
light had some involvement in the treatment of this condition came 
about due to the combination of two key observations. Sister Ward 
was a strong believer in the benefits of fresh air and sunshine in 
improving the health of premature infants and would often walk the 
cots through the hospitals courtyard. On one occasion she observed 
significant changes in the skin tone of jaundiced infants with the 
bleaching of skin exposed to the sun compared to that which was still 
covered. This observation was further corroborated when a sample of 
blood taken from an infant with severe jaundice was tested for plasma 
bilirubin and found to have far lower levels than expected. Upon 
investigation it was found that the sample had been accidentally left 
on a windowsill for some time before being tested. Upon repeating the 
tests bilirubin levels were found to continue to fall upon additional 
exposure to sunlight. The combination of these observations prompted 
Richard Cremer to introduce phototherapy as a treatment for jaundice 
in newborn babies.18 
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The treatment is based on the fact that babies are born without the 
enzymes to breakdown an excess of the fat-soluble chemical bilirubin 
into water-soluble components that can be excreted in urine and stools, 
which a foetus has no requirement to do. For premature infants the 
development of this enzyme may take much longer and the fat-soluble 
bilirubin builds up and is stored in the skin, hence the yellow 
appearance of jaundice babies. It is now widely believed that with the 
influence of light the bilirubin molecule undergoes a photochemical 
cis-trans transformation that results in a product that can be excreted.9 
1.3 The Discovery of Photodynamic Therapy 
The development of modern light therapy is primarily concerned with 
the combination of light and an administered chemical, the 
photosensitiser. There is evidence to suggest that such methods were 
practised in a range of civilizations over the last 3000 years.12 The 
relationship between light and health in combination with pastes and 
ointments is well established through history and has been indicated in 
texts dating as far back as 1550 BC.12 In Ancient India, from evidence 
in the holy book Atharva Veda, and in Ancient Egypt, from the Ebers 
Papyrus, it appears that it was common practice to treat skin 
complaints such as psoriasis and vitiligo with light. Plant-derived 
psoralens, a furocoumarin, were applied to the affected area in the 
form of pastes and ointments and treated in combination with sunlight. 
In fact the furocoumarins contained in plants have been shown to 
make the skin photosensitive, stimulating the production of the 
pigment melanin in the skin.19 
 
The discovery of photodynamic therapy is attributed to Professor 
Herman von Tappeiner. However, it was the work carried out by his 
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medical student Oscar Raab that proved to be the initial discovery and 
foundation of the technique. During the winter of 1897-8 Raab was 
conducting research on the effects of dyes and light on paramecia.20, 21 
An experiment conducted on Insuforia showed unusual results: 
application of an acridine solution and light had a lethal effect. The 
anomalous result was due to a large thunderstorm that Raab noted had 
provided unusually high light levels during the experiment. He 
hypothesised that the death of the paramecium had occurred either due 
to the acridine solution imparting toxic properties to light or that the 
light had somehow transformed the acridine dye into a toxic agent. An 
experiment passing light through an acridine solution before 
illuminating paramecia in an undyed solution proved that light had not 
been changed into toxic radiation. Raab went on to prove that the 
fluorescing properties of acridine had the potential to convert energy 
from absorbed light into an active chemical energy, which was 
responsible for the death of paramecia. It was this active energy that 
formed the foundations of photodynamic therapy. 
 
In 1900 the French neurologist Prime reported the effect of the dye 
eosin as a photosensitiser in humans.22 In a study for the oral treatment 
of epilepsy with eosin it was discovered that exposure of the skin to 
sunlight following drug administration induced dermatitis. Between 
1903 and 1905, based on the discoveries of Raab, von Tappeiner and 
Jesionek made some of the first photodynamic therapy attempts to 
treat tumours and other skin diseases.23 A variety of experiments were 
conducted investigating the potential of dyes, including eosin, 
fluorescein, sodium dichloroanthracene disulfonate and ‘Gruber’s 
Magdalene red’ in treatments. Furthermore, in 1905, von Tappeiner 
published the results of the first photodynamic treatment of six 
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patients with facial basal cell carcinoma. The treatment was performed 
using a 1% eosin solution and a long-term exposure either to sunlight 
or to an arc-lamp, with four out of the six showing total tumour 
resolution. With Jodlbauer, von Tappeiner identified and 
demonstrated the necessity to have oxygen as the third and final 
component in photosensitisation reactions and in 1907 coined the term 
‘photodynamic action’.24  
1.4 Photodynamic Therapy – Importance of Light 
The first light sources used in photodynamic therapy were standard 
lamps for which filters had to be used to define an output wavelength. 
The key drawbacks to this method include the significant thermal 
component and an inability to accurately calculate the light dosimetry. 
The development of lasers in the 1960s provided a light that was 
monochromatic and directional in nature, had a well defined output 
wavelength, and light dosimetry that was easy to measure and 
calculate. It also provided a source of light that can be passed down an 
optical fibre affording the highly localized treatment of affected sites. 
Portable and compact light sources, such as LEDs, are now available 
that can be optimized according to the desired wavelength25, 26 
1.5 Early Photosensitisers 
The discovery of modern, clinically approved photosensitisers can be 
attributed to the initial observations of the tumour-localizing 
properties of porphyrins, revealed by Policard.27 In 1924, Policard 
observed the characteristic red fluorescence of hematoporphyrin when 
experimental rat sarcoma was exposed to UV light. Hematoporphyrin 
was first produced by Scherer in 1841 during experiments 
investigating the nature of blood.28 Dried blood was treated with 
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concentrated sulphuric acid and the precipitate was washed free of 
iron before being treated with alcohol. However, it was not until 1867 
that the fluorescent properties were described and only in 1871 that 
the compound was named as hematoporphyrin.11 In 1911, Hausmann 
performed the first biological studies using HpD and reported the 
effects of light on paramecium and red blood cells, specifically noting 
skin reactions in mice when exposed to light after hematoporphyrin 
administration.29 Lastly, in 1913 the first report of human 
photosensitisation by pophyrins was made by Friedrich Meyer-Betz.30 
In order to determine whether previously observed reactions in mice 
could be induced in humans he injected himself with 200 mg of 
hematoporphyrin and subsequently notice prolonged pain and 
swelling in light exposed areas. Following several publications 
regarding the tumour-localising properties of hematoporphyrin no 
further developments come to light until 1942 when Auler and Banzer 
investigated the localisation and fluorescence of hematoporphyrin in 
malignant tumors.31 In 1948, Figge, Weiland and Manganiello 
demonstrated the potential role of hematoporphyrins as a diagnostic 
tool in oncology due to their preferential absorption by malignant cells 
and characteristic red fluorescence upon illumination.32  
  
In 1955, Schwartz et al. demonstrated that the hematoporphyrin used 
in earlier studies was actually not a single compound, but a complex 
mixture of porphyrins.33 By partial purification Schwartz was able to 
show that the pure isolated hematoporphyrin localized very poorly in 
tumours, yet the residue had a far greater affinity for tumour tissue. In 
his investigations Schwartz treated crude hematoporphyrin with acids, 
in particular acetic and sulphuric, before filtering and further treating 
with sodium acetate to neutralise. Redissolving the precipitate in 
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saline produced a substance which became known as hematoporphyrin 
derivative (HpD). Previous studies, had alluded to the fact that HpD 
may have use in the detection as well as the potential for treatment of 
human tumors.34 
 
In 1972 Diamond et al. suggested the concept that the combination of 
tumour-localising and phototoxic properties of porphyrins could be 
exploited to produce an effective treatment for cancer.35 They went on 
to test whether HpD may serve as a selective photosensitising agent in 
order to destroy tumour cells through exposure to light. In 1975 
Dougherty et al. reported the first successful complete tumour cure 
following administration of HpD.36 However, the clinical approval of 
an HpD based photosensitiser did not occur until 1993, when 
Photofrin® was approved in Canada for the treatment of bladder 
cancer.37 Photofrin® is prepared by removing monomer fractions of 
HpD and, as the first clinically approved photosensitiser, is the 
reference compound by which all new photosensitisers are 
compared.38 
1.6 Designing new photosensitisers 
One of the main complications arising from the design and 
development of an optimised photosensitiser is a distinct lack of 
knowledge concerning the biological mechanisms involved in 
photodynamic therapy. It is currently accepted that an administered 
photosensitiser is preferentially absorbed by malignant cells where it 
remains dormant until excited with light. Upon absorption of light the 
photosensitiser forms excited states that react with molecular oxygen 
to generate singlet excited states of oxygen, which leads to cell death. 
1.6 Designing New Photosensitisers 
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The target and mechanism by which this cell death occurs has yet to 
be fully identified. Research targeted at identifying the mode of action 
of Photofrin® suggests that mitochondrial sites may be the targets for 
optimal photodynamic action.8 However, evidence suggests that 
vascular shutdown occurs as a reaction of singlet delta oxygen with 
the unsaturated lipids and proteins of biological membranes.39 The 
reaction step from sensitizer to molecular oxygen with subsequent cell 
death and a combination of lack of a defined biological target makes 
photosensitiser optimisation using potential structure activity 
relationships a difficult task.40 Consequently, the research to date has 
centred on the development and enhancement of HpD, Photofrin® and 
compounds related in structure to porphyrins. 
 
Following the approval of Photofrin® as a photosensitiser in 
photodynamic therapy of bladder cancer, the natural course of action 
has been to identify the photodynamically active component. 
N
H
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N
N
CH3R
H3C
C
O(CH2)2
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CH3
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CH3
O
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n  
Figure 1. 1 Structure of Photofrin®, the first clinically approved photosensitiser. 
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Photofrin® comprises a complex mixture of porphyrin isomers and 
oligomers, of which a sole active component has yet to be identified, 
Figure 1.1.41 It may in fact be the case that the inherent success of the 
drug is the relationship between the mixture of molecules. Other 
shortfalls of Photofrin® include a weak absorption at the therapeutic 
wavelength, εs = 3 x 103 M-1 cm-1 at 630 nm, poor tumour selectivity 
and only moderate singlet oxygen quantum yields, typically 
ΦΔ ~ 0.2.42-44 It follows that in the design of an optimised 
photosensitiser a number of conditions can be optimised,8, 10, 43, 45-47 
these are as follows: 
1.6.1 A Single Substance 
The complications associated with Photofrin® are largely centred on 
its complex composition of isomers and oligomers and the problems 
in the identification of an active component. Hence, there is great 
benefit in synthesising an efficient photosensitiser that consists of one 
compound, whereby it is hoped that the biological targets can be 
identified. 
1.6.2 Tumour Selectivity 
Photodynamic therapy is built on early research following the 
localisation of HpD in malignant cells. Tumour selectivity provides a 
huge advantage in the treatment of cancer as it means that healthy 
cells remain undisturbed and so minimises the risks of recurring 
illness and secondary cancers as can be experienced by patients being 
treated with chemotherapy and radiotherapy.  
1.6.3 Stability and Toxicity 
It is of great importance that any potential photosensitiser does not 
cause further damage or new illnesses to the patient. The benefit of 
1.6 Designing New Photosensitisers 
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Photofrin® is that it is a product of dried blood and therefore a 
naturally occurring biological molecule with a well established 
metabolic pathway. The dangers associated with any alien compound 
introduce to the body are not only what the compound itself can do, 
but also the risks associated with any by-products of metabolism. It is 
important, therefore, that the molecule is relatively stable, but also 
clears rapidly from the body post-treatment. 
1.6.4 Amphiphilicity 
Amphiphilicity is important as the drug is usually administered in an 
aqueous environment but to get into a cell has to cross fat based cell 
membranes. It takes into account the aqueous and fatty environments 
encountered both inside and outside the cell. 
1.6.5 Red Absorption 
Light penetration through tissue and tumours is limited by optical 
scattering within the tissue, the absorption of light by biological 
chromophores and the physiochemical features of the photosensitiser. 
Typically, the region where biological chromophores, such as 
haemoglobin and oxyhaemoglobin, have minimum absorption is at 
wavelengths greater than 600 nm. Water is another key component of 
cells, absorbing light at wavelengths greater than 1200 nm. The 
minimum energy required to generate singlet oxygen is 
94 kJ mol-1 which corresponds to a wavelength of 1270 nm. Thus the 
triplet state of the photosensitiser must exceed this energy. It has been 
well documented that the photophysical sequence is affected by 
thermal losses such that the upper limit for a photosensitiser to 
efficiently produce singlet delta oxygen is 140 kJ mol-1, which 
corresponds to a wavelength of 850 nm.48 Hence, to maximise the 
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effectiveness of the technique it is important to develop 
photosensitisers with high molar extinction coefficients in the optical 
window of 600 – 850 nm  in order to increase the penetration depth of 
the treatment. 
1.6.6 Fluorescence 
It is broadly accepted that an efficient photosensitiser should have 
minimal fluorescence.49 Hence the absorbed energy is not lost through 
emission, but rather, transferred to the triplet state of the molecule via 
spin-forbidden intersystem crossing. However, there may be some 
argument for the benefits of a small amount of fluorescence in order to 
identify whether there is photosensitiser localisation and therefore the 
maximum thresholds for absorption of the photosensitiser by 
malignant cells and optimum treatment windows. 
1.6.7 Triplet Energies and Quantum Yields 
The optical window is defined, in part, by the minimum energy 
required to generate singlet delta oxygen via the triplet state of the 
photosensitiser. Triplet energies must exceed 100 kJ mol-1 to allow for 
efficient energy transfer to ground state oxygen. High quantum yields 
and long triplet lifetimes increase the efficiency of singlet delta 
oxygen production.  
1.6.8 Singlet Delta Oxygen Quantum Yields (ΦΔ) 
Singlet delta oxygen, O2(1Δg), is believed to be the component 
responsible for cell death so it is important to generate it as efficiently 
as possible. The quantum yield is the ratio of singlet delta oxygen 
states formed compared to the number of photons initially absorbed by 
the photosensitiser. Quantum yields approach unity if the triplet state 
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of the photosensitiser is formed efficiently and is fully quenched by 
molecular oxygen.  
1.7 Second-Generation Photosensitisers 
In an attempt to find the optimum photosensitiser, thousands of 
compounds have been synthesised and the details published over the 
last 30 years.50 Many claiming to be novel photosensitisers have 
turned out not to be optimal for oncology based photodynamic therapy, 
however some shining examples have appeared that have potential as 
photosensitisers in other medical arenas. The photosensitisers 
reviewed are all loosely related in structure and will be broken down 
into 3 core families, porphyrins, chlorins and phthalocyanine dyes, 
Figure 1.2. 
1.7.1 Porphyrins 
Investigating porphyrins is the natural approach to take in the 
development of photosensitisers from Photofrin®. The core structure 
allows for countless variations, which in turn can be used to fine-tune 
some of the key properties required for PDT. Research shows that 
porphyrins can be substituted at the reactive pseudobenzylic position 
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Figure 1. 2. Illustration of the core structures, form left to right, of porphyrins, chlorines 
and phthalocyanines. 
1.7 Second Generation Photosensitizers 
 16 
with a variety of functional groups including ethers, thioethers, esters 
and amines, all of which have shown to exhibit some biological 
activity.51 However, efforts to enhance absorption in the red region 
have had only small influences on both shift and improvement of 
molar extinction coefficients. 
 
One remarkable and unique discovery has been the identification and 
exploitation of aminolevulinic (ALA) acid induced in vitro 
photosensitisation, as discovered in 1987 by Malik and Lugaci.52 
Though ALA itself is not a porphyrin and has no intrinsic 
photosensitising properties, an excess of the compound in cells 
disrupts the haem biosynthetic pathway, of which it is a naturally-
occurring intermediate and precursor of the photosensitising agent 
protoporphyrin IX (PpIX), Figure 1.3. The topical application of the 
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Figure 1. 3. Structure of protoporphyrin IX (PpIX) formed in situ when the haem 
biosynthetic pathway is disrupted with the application of excess ALA. 
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hydrophilic porphyrin precursor disrupts the negative feedback 
mechanism and stimulates the body into producing an excess of PpIX, 
which, when combined with light, produces a photodynamic effect. 
The advantages are immediately clear as the photosensitiser is 
synthesised in situ, hence eliminating issues addressed with 
administering the drug and transporting it to the correct location. It is 
also a naturally occurring compound so can be metabolised by the 
body and rapidly cleared post treatment without the threat of toxic by-
products. The treatment uses light with wavelength of 630 – 635 nm, 3 
– 6 hrs after application. The key drawback seems to be an upper 
limitation of 1 mm for penetration depth, so it is best used on tumours 
at relatively small depths.53 
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Figure 1. 4. Structure of Visudyne, a photosensitiser used in the treatment of AMD. 
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1.7.2 Chlorins 
Chlorins are modified porphyrins, Chlorophyll a falls into this 
category and is already well known for its photophysical properties 
through its role in photosynthesis. A key development in this area has 
been the research into the benzoporphyrin derivative mono acid, 
commercially known as Visudyne and Verteporfrin, Figure 1.4.54 This 
compound exhibits a significant red-shift in Band I, with absorption at 
690 nm and good biological activity. The drawbacks, however, are 
that it clears very rapidly from biological tissue, both malignant and 
healthy, resulting in poor tumour selectivity. However, where this 
drug fails in photodynamic therapy for oncology it has enormous 
potential in the treatment of age-related macular eye degeneration 
(AMD). The wet-form of AMD is currently a leading cause of 
blindness in the over 50s in the western world. It involves the 
abnormal growth of blood vessels in the eye, which subsequently 
leads to loss in central vision. Prior to AMD-PDT the course of 
treatment followed involved thermal laser coagulation to cauterise the 
leaky vessels, with little effect. However, intravenous administration 
of Visudyne gives a 3 hr therapeutic window during which a 3 mm 
spot at the neovasculature can be illuminated. This results in sealing of 
the leaky vessel, which cannot restore lost eyesight, but does slow 
down and even halt further vision loss.55 
 
Another example of a chlorin-based photosensitizer is m-THPC, 
commercially known as Foscan, Figure 1.5.56 Foscan is of particular 
interest because, on paper, it fulfils many of the criteria for an 
optimised photosensitiser. It has comparable singlet oxygen quantum 
yields to other chlorins, it has red absorption at 660 nm and requires 
only low doses to achieve the same results as Photofrin®. The 
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problems arising from the potency of the drug and its efficient ability 
to convert light energy combined with the necessity for a 4 day delay 
between drug administration and treatment. Foscan appears to be so 
potent that extreme measures have to be taken in order to block any 
healthy tissue from reflected and scattered light prior to treatment. 
Patients are also susceptible to damage out of direct light so treatment 
needs to be administered in dark rooms. Part of the problem is that 
there is far greater penetration with Foscan than expected, which may 
be a property unique to this drug, but also may be in part due to 
differences in optical properties of tumours compared with healthy 
tissue. Even the rhythmic motion of patients breathing can be 
detrimental to the success of the technique as the movement can lead 
to either under dosage to the tumour or over dosage to healthy skin. 
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Figure 1. 5. Structure of Foscan. 
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Current research is involved in toning down the potency by 
administration of green light, which has a much reduced penetration.  
1.7.3 Dyes 
Some researchers believe that a step backwards to the original 
research by Raab is an appropriate way to develop photosensitisers.57 
Raabs work was based around the properties of a number of dyes. 
Phthalocyanines are blue dyes that have been extensively used in the 
dyes and pigments industries and may have great potential in 
photodynamic therapy. 
1.8 An Introduction to Phthalocyanines 
The word phthalocyanine originates from the Greek for naphtha 
meaning ‘rock oil’ and cyanine meaning ‘dark blue’, a reflection of 
the intense blue colour of these compounds. As is so often the case in 
science, the discovery of phthalocyanines came about accidentally. 
Literature tells us that four chemists working at Scottish Dyes Ltd. 
observed an insoluble blue material during the routine manufacture of 
phthalimide from phthalic anhydride, both of which are white solids.58 
A letter written by Ron Grieg, the analytical chemist of the department 
working at Scottish Dyes Ltd. at the time, and reproduced by Gregory 
illustrates a more colourful version of events.59 Grieg states that, in a 
bid to prove negligence of the foreman in the contamination of the 
reaction with a blue dye manufactured in the same place, analysis 
performed on the mystery compound actually found it to be an 
organo-iron compound. The structure was later elucidated as iron 
phthalocyanine through studies by Linstead et al. in 1929 and further 
proved by Robertson through X-ray diffraction.60-67 In hindsight, the 
first recorded observation of a phthalocyanine was made in 1907 when 
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Braun and Tcherniac observed the production of a coloured impurity 
with unknown structure and origin in the reaction of phthalamide and 
acetic anhydride to produce o-cyanobenzamide.68 Nevertheless, 
Scottish Dyes Ltd. went on to get the first patent in 1928 and began to 
exploit the visible properties of phthalocyanines through synthesis of a 
series of copper phthalocyanine dyes.69 
 
Phthalocyanines are large macrocyclic systems containing 18-π 
electrons and comprising of four modified pyrrole units. These 
compounds are structurally similar to earlier first generation 
photosensitisers, specifically porphyrins and chlorins. Phthalocyanines 
are a particularly attractive family of compounds to study as the 
synthetic pathways allow for a number of systematic modifications to 
be made to the molecule, including metal centres, axial ligands and 
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Figure 1. 6. Structure of the phthalocyanine molecule illustrating positions for alpha 
substitution (R = 1 and 4) and beta substitution (R = 2 and 3). Axial modification can also 
be applied to the central metal ion. 
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incorporation of substituents in the alpha (1 and 4) and beta (2 and 3) 
position, see Figure 1.6. Such changes can be used to fine-tune key 
physical and photophysical properties of these compounds. 
 
In addition to modifying phthalocyanines by the incorporation of 
substituents, Linstead et al.70 showed it was possible to synthesise 
unsymmetrical phthalocyanine derivatives by the reaction of 
methylmagnesium halide with phthalonitrile to yield magnesium 
phthalocyanine structures with a modified internal cavity. In these 
compounds one, two, three or all of the aza links are exchanged for 
methine links, giving tetrabenzotriazaporphyrin (TBTAP), 
tetrabenzodiazaporphyrin (TBDAP) and tetrabenzomonoazaporphyrin 
(TBMAP) and tetrabenzoporphyrin (TBP), respectively, as illustrated 
in Figure 1.7. It is believed that these unsymmetrical systems may 
have potential in photodynamic therapy and provide higher stability 
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Figure 1. 7. Schematic diagram illustrating the structural modifications from  
phthalocyanine to tetrabenzoporphyrin. 
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and efficiency than the generally less stable porphyrin equivalents. 
Due to a challenging synthesis little is known about these compounds, 
and how they fair against their phthalocyanine counterparts. Only 
recently, Cook et al. have reported the facile synthesis of a series of 
alpha octa-alkyl substituted H2 and Mg phthalocyanines with an 
emphasis on the absorption spectra and crystallographic data, opening 
up the opportunity to study similar systems with a variety metal 
centres and benzenoid substituents.71 
 
Since their discovery, phthalocyanines have been extensively utilised 
in the dyes and pigments industries due to high thermal, chemical and 
photochemical stabilities.59 Unbeknownst to many, phthalocyanines 
are commonly encountered in everyday life in products such as the 
blue coating on re-writeable compact discs and cyan inks in printers. 
In fact extensive research over the last three decades has shown 
phthalocyanines to have potential application in fields as diverse as 
solar cells, photocopiers, catalysts and semi-conductors.58 
 
The intense blue-green colour exhibited by phthalocyanines was the 
primary motivation prompting the investigation and subsequent 
exploitation of these compounds by the dyes and pigments industries. 
However, on closer inspection of the absorption spectrum of these 
compounds it is immediately evident that this property fulfils the 
absorption requirements of an ideal photosensitiser. Figure 1.8 shows 
a typical absorption spectrum of metal-free and metallated 
phthalocyanine. The spectrum contains five main bands labelled Q, B 
(or Soret), N, L and C.72-75 The four highest energy bands (B, N, L and 
C) absorb in the UV region of the spectrum. The B band is typically a 
broad band between 320 – 370 nm and is the second most intense 
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band arising from π – π* transition. The remaining three bands (N, L 
and C) occur at higher energy than this, typically observed between 
210 – 280 nm. These bands are typically not used in the analysis of 
phthalocyanines and will not be discussed further. In the case of 
phthalocyanines, the Q-band, in the red region, is the most intense and 
distinctive absorption band and is responsible for the intense colour 
exhibited by unaggregated monomeric phthalocyanines. This band is 
assigned to a π – π* transition. In the example given it is obvious that 
there is a distinct difference in Q-band structure between the metal-
free and metallated phthalocyanine. In the case of the metallated 
compound, a single ion placed at the centre of the phthalocyanine 
structure gives the molecule D4h symmetry. This leads to a doubly 
degenerate excited state, thus the Q-band exhibits a sharp single peak. 
Two ions, as in the case of the metal-free compound, reduces the 
symmetry to D2h, which results in the degeneracy being lifted and the 
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Figure 1. 8. Absorption spectrum of metal-free phthalocyanine and metallated 
phthalocyanine, containing zinc(II) in the central cavity, illustrating the distinct 
absorption in the red region of the UV-vis spectrum. 
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Q-band separating into two well-defined peaks, Qx and Qy, at lower 
and higher energy, respectively. In addition to this, the absolute 
position of the Q-band maxima can vary by 100 nm according to the 
central metal ion such that the greatest blue-shift occurs with iron(II) 
inserted into the central cavity and the greatest red-shift occurs with 
the incorporation of manganese(II).76   
 
Phthalocyanines are promising candidates as photosensitisers not only 
due to the intense red absorption, but also due to low fluorescence 
quantum yields, high triplet quantum yields and long-lived triplet 
states. They also typically exhibit high singlet oxygen quantum 
yields.77, 78  
 
Over the past four decades a great interest has been placed on 
investigating the unique and diverse properties of phthalocyanines, in 
particular zinc and silicon phthalocyanines and more recently 
palladium derivatives which have shown a great potential for 
application in PDT. Subsequently, research has concentrated on the 
ability to optimise physical and photophysical properties including 
solubility, Q-band absorption, triplet state properties and singlet delta 
oxygen quantum yields. Tuning of such properties can be achieved by 
the substitution of functional groups in the alpha (1, 4) and beta (2, 3) 
position. 
 
Herein three series of alpha octa-alkyl phthalocyanines, as defined by 
the metal-ion centre, will be studied in relation to potential application 
of these compounds as photosensitisers in PDT. Each series will 
contain silicon, zinc or palladium in the central cavity and will be 
substituted with alkyl chains of carbon length in the range 1 – 15, 
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which have previously been shown to enhance solubility. In addition 
to this an alpha octa-alkyl zinc tetrabenzotriazaporphyrin substituted 
with hexyl chains will also be examined. Standard techniques will be 
used to determine fluorescence and triplet data. The approach to the 
determination of singlet delta oxygen quantum yields will be 
discussed and investigated and two methods will be considered for the 
calculation of these values. Where possible results will be compared 
to unsubstituted parent compounds in order to evaluate the effects of 
systematic modifications to the phthalocyanine molecule. 
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2. Experimental Methods 
2.1 Materials and Synthesis 
All experiments were carried out in 1% v/v pyridine in toluene unless 
otherwise stated.  The phthalocyanine derivatives under investigation 
were synthesised by another group in our department who describe the 
synthesis in detail elsewhere.1 Substituted zinc, silicon and palladium 
phthalocyanines were investigated here.  Each compound has a 
different length alkyl substituent in the alpha position.  The 
compounds are referred to as nMPc, whereby n represents the number 
of carbons on the alkyl chain and M refers to the metal centre for 
example 6ZnPc is zinc phthalocyanine substituted in the alpha 
position with hexyl groups.  The standards used in this work were zinc 
phthalocyanine, ZnPc (97 %), perinaphthenone, PPN (97 %), and zinc 
tetraphenylpyridine, ZnTPP, which were obtained from Aldrich and 
used without further purification.  HPLC grade toluene (99.99 %) and 
pyridine (≥99.5 %) were obtained from Aldrich. 
2.2 Spectroscopic Studies 
UV-visible spectra were recorded on a Hitachi U-3000 
spectrophotometer using 1 cm matched quartz cuvettes.  The molar 
absorptivity was calculated from a least squares fit of absorbance 
against concentration. Steady-state fluorescence spectra were acquired 
on a Horiba Jobin Yvon Fluoromax-2 with 2 nm slit width for both 
excitation and emission monochromators. 
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2.3 Photophysics 
2.3.1 Fluorescence Quantum Yields 
Fluorescence quantum yields, ΦF, were determined using the 
comparative method described in detail elsewhere.2 The fluorescence 
quantum yield is related to that of a standard by: 
  
2
std
F F,std 2
std std
A Fn
F n A
      (eq. 2.1) 
Where F and Fstd are the areas under the fluorescence emission curves 
of the samples (a-h) and the standard, respectively.  A and Astd are the 
respective absorbances of the samples and standard at the excitation 
wavelength, respectively, and n and nstd are the refractive indexes of 
solvents (ntoluene = 1.4961 (at 20 °C and 589 nm); nethanol = 1.3611 (at 
20 °C and 589 nm); npyridine = 1.5095 (at 20 °C and 589 nm); ntol/py 
taken to be 1.50.3 Unsubstituted ZnPc (in EtOH) (Φf = 0.28)4 was 
employed as the standard.  The absorbance of the solutions at the 
excitation wavelength ranged between 0.02 and 0.1. 
2.3.2 Fluorescence Lifetimes 
The technique of time correlated single photon counting (TCSPC) was 
used to record fluorescence lifetimes of the samples.  All solutions 
under study were prepared with a concentration so as to give a 
maximum absorbance at the Q-band of no greater than 0.05, in order 
to eliminate the effects of re-absorption.  The excitation source 
consisted of a pulsed 635 nm diode laser (IBH NanoLED Model-02) 
providing output pulses of <200 ps at a repetition rate of 1 MHz.  The 
fluorescence emission was collected at 90° to the excitation source, 
and the emission at  = 716 nm recorded using a cooled, red sensitive 
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photomultiplier tube (IBH Model TBX-04) linked to a time-to-
amplitude converter (Ortec 567) and multichannel analyzer (E.G & G. 
Trump Card and Maestro for Windows V.5.10).  The instrument 
response function (IRF) of the apparatus was measured using a dilute 
suspension of milk powder in water as a scattering medium giving an 
IRF with a duration of 450 ps full width at half maximum (FWHM).  
The time per channel was typically ~25 ps giving a full range of 
~50 ns over the 2048 point data set.  All fluorescence decays were 
recorded to a minimum of 10,000 counts in the peak channel of the 
pulse height analyzer.  The data were transferred to a computer and 
analysed by using the standard method of iterative reconvolution and 
non-linear least squares fitting in a Microsoft Excel spreadsheet.  The 
quality of calculated fits was judged using statistical parameters 
including the Durbin-Watson parameter, reduced 2, random residuals 
and autocorrelated residuals. 
2.3.3 Triplet Quantum Yields and Lifetimes  
Triplet-triplet absorption spectra, triplet extinction coefficients, 
lifetimes and quantum yields were measured using a standard method, 
described in detail elsewhere.5 Briefly, the data were recorded on a 
laser flash photolysis system.  The excitation pulses were provided by 
the third-harmonic of a Q-switched Nd:YAG laser (JK 2000).  Pulse 
energies were between 0.1 – 1 mJ and the excitation beam was 
directed through the sample without focussing.  The analyzing source 
was a tungsten-halogen lamp imaged into the sample cuvette at right 
angles to the excitation beam.  The analyzing source was subsequently 
relay imaged onto the entrance slits of a 50 cm monochromator and 
detected with a photomultiplier tube (EMI 9529B).  Transient 
absorption spectra were collected by measuring two time gates, from 0 
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– 25 μs and 30 – 80 μs.  These were simultaneously recorded onto 
computer from the two-channel digital real-time oscilloscope (LeCroy 
Waverunner LT262).  Transient decay signals were averaged for 1024 
pulses using the oscilloscope and written directly to disk.  All the 
sample solutions were degassed, using the freeze-pump-thaw 
technique and irradiated in a 10 mm path-length quartz cell.  
2.3.4 Steady-state Luminescence 
The phosphorescence spectrum for palladium phthalocyanine 
derivatives was measured on a home-built system. The sample was 
excited at 633nm with a HeNe laser (5 mW), the luminescence 
collected at 90 degrees and focused onto the entrance slit of 
monochromator (Bentham TM-300) equipped with a NIR optimised 
grating (600 grooves/mm, 1 micron blaze).  The selected wavelength 
was focussed onto a Hamamatsu NIR photomultiplier tube (H10330B-
45) operating at -800V in photon counting mode.  The photon count 
rate was measured using a digital i-o card (National Instruments PCI-
6601) as a function of the selected wavelength allowing the emission 
spectrum to be recorded.  The spectrometer was controlled by a home-
written program (LabVIEW). 
2.4 Singlet Delta Oxygen Quantum Yield Determination 
2.4.1 Time-Resolved Singlet Oxygen Phosphorescence 
Detection (TRPD) 
The singlet delta oxygen quantum yield, ΦΔ, was determined using a 
similar method to those described in previous work.6, 7 Samples 
dissolved in 1% v/v toluene/pyridine, to minimize aggregation, and 
allowed to equilibrate with air were excited using the third harmonic 
of a Q-switched Nd:YAG laser (355 nm).  A CoSO4 filter was used 
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upstream of the solution to remove residual 1064 nm radiation.  
Typical pulse energies used were in the range 0.1-1 mJ per pulse.  A 
North Coast E0-817P Ge photodiode/amplifier combination detected 
the singlet oxygen phosphorescence at right angles to the incident 
laser beam.  The sample was placed in a fluorescence cuvette with a 
10 mm path length close to the detector.  The singlet oxygen 
luminescence was selected with a 1270 nm silicon interference filter 
(bandpass, 30 nm) placed close to the detector. 
2.4.2 Time-Resolved Thermal Lensing 
The TRTL signal was collected using a similar method to those 
described in previous work.8 Samples were excited using the third 
harmonic of a Q-switched Nd:YAG laser (355 nm) focused onto the 
front of the cuvette using a lens of 100 mm focal length. Typical pulse 
energies were in the range 0.1 – 1 mJ per pulse at a frequency of 
10 Hz. A cw HeNe laser (633 nm) with energy of 2 mW was used to 
probe the samples by focusing into the cuvette using a lens of focal 
length f = 50 mm. A silicon photodiode combined with a trans-
impedance amplifier or a photon multiplier tube used to detect the 
probe beam. The sample was placed in a fluorescence cuvette with a 
10 mm path length. The probe beam was selected with a 
monochromator set to 633 nm placed close to the detector.  
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3. Singlet Delta Oxygen, O2(1Δg) 
3.1 Introduction 
The science and chemistry of ground state molecular oxygen (O2) has 
been widely studied for centuries. Despite the apparent simplicity of 
the oxygen molecule it exhibits a variety of unusual properties with 
respect to magnetic behaviour, spectroscopy, energy-transfer and 
chemical reactivity.1 Furthermore, molecular oxygen is essential to 
animal respiration and life. Oxygen also plays a significant role in 
photodynamic therapy as one of the three controlling factors; the other 
two factors are light and the chemical photosensitiser.2 The key 
process in PDT appears to be the death of cells by the formation of 
cytotoxic oxygen, though the precise biological mechanism in this 
step is not yet fully understood and may in fact vary on a case by case 
basis.3 
 
The cytotoxic oxygen referred to throughout literature is more 
accurately ascribed to a low-lying excited state of molecular oxygen. 
In 1928, Mulliken applied the molecular orbital theory to the oxygen 
molecule and predicted the existence of two low-lying excited singlet 
states.4 The well known Fraunhofer line observed at 157 kJ mol-1 
corresponds to the transition from the ground state to one of these 
singlet states and is due to the absorption spectrum of oxygen in the 
Earth’s atmosphere.5 Mulliken went on to claim that another singlet 
level existed with lower energy, predicting that the other singlet state 
would lie at approximately 79 kJ mol-1 above the ground state. It is 
now commonly accepted that the two electronically excited states 
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arise from the same 
configuration, but have 
different spin pairings of the 
two electrons. This leads to a 
1Σg+ state at 157 kJ mol-1 and a 
1Δg at 94 kJ mol-1 above the 
3Σg ground state, as illustrated 
in Figure 3.1.6 Though the 
electronic transitions are 
highly spin forbidden both are 
observed in the absorption and 
emission spectra in the upper 
atmosphere, with zero-zero transitions at 1269 nm (1Δg ← 3Σg) and 
762 nm (1Σg+ ← 3Σg) and estimated radiative lifetimes of 64 minutes 
and 10 seconds, respectively.7 The measured lifetimes in gas and 
solution phase are significantly shorter and, in condensed media, the 
lifetime of O2(1Σg+) is so short lived that little is known about the 
properties of the state, thus the term singlet oxygen refers primarily to 
the 1Δg state. 
 
As early as 1931, Kautsky proposed that singlet oxygen was a possible 
intermediate in dye-sensitised photoreactions formed via the 
fluorescent and metastable states of dyes.8 Furthermore, this theory 
was proved by performing an experiment in which photosensitised 
oxygenation of substrate molecules was observed when the substrate 
and photosensitiser molecules were absorbed on different silica gel 
grains. The experiment showed that the intermediate responsible for 
photo-oxygenation was gaseous oxygen. However, these ideas were 
considered too radical for their time.9 It was not until 1963 that Khan 
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Figure 3. 1. A molecular orbital diagram 
illustrating the spin pairings of the electrons in 
the ground state and simplified diagrams of 
both excited states. 
3.1 Introduction 
 40 
and Kasha interpreted the chemiluminescence of the hypochlorite-
peroxide reaction as caused by liberated singlet oxygen.10 Then, in 
1964, the original ideas proposed by Kautsky were revisited in 
publications by Foote and Wexler and Corey and Taylor.11 
Furthermore, in 1972 Adams and Wilkinson developed a method for 
measuring the lifetime of singlet oxygen in solution, which paved the 
way for direct time measurements of singlet oxygen with a reactive 
substrate.12 In 1976, Krasnovsky used a mechanical phosphorescence 
to detect the weak luminescence of O2(1Δg) at 1269 nm,13 revealing 
kinetic information about singlet oxygen on the millisecond 
timescale.14, 15 Following the development of sensitive germanium 
photodiodes in the 1980s, phosphorescence studies of O2(1Δg) on a 
microsecond timescale became routinely possible. 
 
Between 1933 and 1935 Jabłonski reported an energy-level diagram in 
which it is illustrated that dye molecules possess two states, a short-
lived fluorescence state and a long-lived metastable state.5 In 1943, 
Terenin assigned the fluorescence state of these dyes as singlet and the 
metastable state as triplet, notations that are still in use today. As has 
previously been discussed, rather unusually, the opposite is true for 
the assignment of the ground and excited states of molecular oxygen. 
 
It is now understood that O2(1Δg) can arise as a result of several 
mechanisms involving the excited states of dyes. The two core 
categories of photosensitised singlet oxygen formation are classified 
as Type I and Type II mechanism.16, 17 In a Type I mechanism it is the 
formation of radicals by hydrogen-abstraction or electron transfer 
between an excited sensitiser and substrate that proceeds to react with 
molecular oxygen to form the superoxide radical anion. In a Type II 
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mechanism the excited sensitiser interacts directly with molecular 
oxygen resulting in an energy transfer and the formation of singlet 
delta oxygen, illustrated in the expanded Jabłonski diagram, 
Figure 3. 2.  
 
The efficiency of a photosensitiser in relation to its ability to generate 
singlet delta oxygen is known as the singlet delta oxygen quantum 
yield (ΦΔ). This is defined as the ratio of the number of absorbed 
photons to the number of singlet delta oxygen states that are formed.18-
20 A high quantum yield, typically defined as over 0.5, signifies that 
the photosensitiser will efficiently convert the absorbed energy into 
singlet delta oxygen. This is highly desirable as the ultimate advantage 
is a reduction in drug concentration or levels of radiation or, in an 
ideal situation, reduction of both parameters. There are a wide variety 
of techniques now established for the determination of ΦΔ including, 
direct methods of detecting the luminescence, with time-resolved or 
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Figure 3. 2. Jablonski diagram illustrating the energtic pathways in the formation of 
singlet delta oxygen via the excited states of a dye photosensitizer in a Type II 
mechanism.  
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steady-state infrared luminescence, calorimetric techniques using 
photo acoustic calorimetry or time-resolved thermal lensing and the 
quantitative analysis of photooxidation reactions, monitoring either 
the loss of absorption or fluorescence of a quencher on oxygen uptake. 
 
As has previously been mentioned, the advent of the germanium 
photodiode in the 1980s led to the development of one of the most 
widely used methods for the determination of ΦΔ, the direct detection 
of the weak singlet oxygen phosphorescence in the near-infrared.20 
This technique is known as time-resolved near-infrared 
phosphorescence detection.21, 22 An example of a typical experimental 
set-up can be seen illustrated in Figure 3.3. A potential photosensitiser, 
with absorption of less than 0.1 at the excitation wavelength, is 
excited with a pulsed laser and the singlet oxygen luminescence 
generated by the excitation of oxygen via the excited states of the 
photosensitiser is detected. From this it is possible to determine the 
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Figure 3. 3. Schematic diagram of a time-resolved singlet oxygen phosphorescence 
spectrometer, λex  =  355  nm 
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emission intensity of singlet delta oxygen phosphorescence, S(0), 
when t = 0. 
  
It follows that the intensity of emission of singlet oxygen 
phosphorescence is proportional to concentration of singlet oxygen 
such that: 
))](([)( 122 tOktS gr
r
 
   (eq. 3. 1) 
where, κ is the proportionality constant, including geometrical and 
electronic factors of the detection system, ηr is the refractive index of 
the solution and kr is the solvent-dependent O2(1Δg) radiative decay 
constant.20 In order to obtain ΦΔ the following relationship, 
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where, τΔ and τT are O2(1Δg) and triplet lifetimes, respectively. Hence, 
if the triplet lifetime is much shorter than the O2(1Δg) lifetime, such as 
τT « τΔ, and t > 5τT then the intensity can be described as, 
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and S(0), the signal intensity at t = 0, is given as, 
VhN
EkS
A
A
r
r 
 )()(


 1010 1
2   (eq. 3. 4) 
where, E1 is the energy of the laser pulse, A is the absorbance of the 
solution, NA is Avogadro’s constant, h is Planck’s constant, υ is the 
laser frequency and V is the irradiated volume. Calculating the ratio of 
S(0) for a sensitiser and reference measured under the same 
geometrical conditions with the same laser energy and absorbance 
affords the relative value of ΦΔ, this is illustrated in Figure 3. 4. 
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A key component of the success of this technique is the choice of 
standard, which, ideally should exhibit a similar absorption spectrum 
as the sample dye, can be measured in the same reaction conditions, 
for example, solvent system and excitation wavelength, and has ΦΔ 
close to unity. The use of standards, defines the first limitation of this 
technique, another key disadvantage is that less than 10-3 of O2(1Δg) 
states formed decay by a radiative pathway.23 Furthermore, any 
quenching species, impurities, present in the sample can significantly 
distort the quantum yield.24 
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Figure 3. 4. An example of data analysis for a typical TRPD experiment. Singlet oxygen 
phosphorescence decay for PPN (a) and sample (b) at varying power. Slopes of the 
intensity relationship with power for varying power (c) followed by the relationship with 
concentration (d). 
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In more recent years, a technique that has gained popularity is that of 
ΦΔ determination by the quantitative analysis of photo-oxidation 
reactions. In particular, the two chemical quenchers most commonly 
chosen are diphenylbenzofuran, DPBF, in DMSO and bilirubin 
ditaurate, BDT.25 Samples are irradiated at the Q-band, between 630 
and 720 nm, and the absorption decay of the chemical quencher is 
monitored, in the case of DPBF this is at 417 nm. The photobleaching 
rate of the DPBF for the sample is measured and compared to that of a 
standard using the following relationship, 
std
abs
abs
std
std RI
RI
,    (eq. 3. 5) 
where, subscript std refers to the standard, I is the intensity of 
absorbance and R is the rate of decay. In the case of studies performed 
on phthalocyanines the standard typically used is ZnPc with ΦΔ = 0.56 
in DMF and ΦΔ = 0.67 in DMSO.26 To date, this technique has been 
used to calculate quantum yields with an accuracy of 10-15%.27 
 
Both singlet delta oxygen luminescence and photo-oxidation 
quenching techniques have been proven to provide singlet oxygen 
quantum yields that are comparable with one another once 
geometrical and experimental variations are eliminated owing to the 
process of comparison. Such techniques are indeed widely understood 
and used successfully within their field with typical uncertainties in 
the region of 5  - 10%.24 However, the main objective in determining 
ΦΔ in this study is in the context of photodynamic therapy where the 
excitation source is required to coincide with the optical window, in 
the range of 600 – 850 nm. It is evident that current techniques do not 
adequately reproduce in vivo conditions, which is in part due to the 
nature of the techniques, but also largely due to the dependence upon 
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standards which add a number of external constraints to the 
measurements. This is further hindered by a dependence upon aging 
techniques and vintage instruments, thus, with the development and 
subsequent availability of more efficient detection and laser systems, 
there is some argument for the modernisation of singlet oxygen 
quantum yield determination.28  
 
With this in mind there has been a move to update ΦΔ techniques to 
reflect the rate at which technology has developed over the last 50 
years and determine a means of elucidating absolute ΦΔ, and in doing 
so eliminate the dependence upon standards. Such methods focus 
predominantly on the energy lost through non-radiative pathways that 
is detected as localised changes in heat or pressure, brought about by a 
change of temperature within the excited area of the sample. Examples 
of such techniques include light-induced optoacoustic calorimetry, a 
pressure based technique, and photothermal blooming, which is heat 
based.29 These techniques are considered to be more sensitive than 
traditional comparison techniques as the loss of energy from the 
singlet delta oxygen state is favoured by non-radiative pathways over 
the radiative.24 
3.2 Time-Resolved Thermal Lensing 
Time-resolved thermal lensing, TRTL, is a familiar technique in the 
field of absolute fluorescence quantum yield determination.30-36 The 
thermal lens was initially discovered by Gordon et al. in 1965. During 
efforts to increase the intensity of laser Raman scattering it was noted 
that the laser light had been subjected to divergent effects of a lens 
upon insertion of a benzene sample within the resonator of the HeNe 
laser. It was concluded that the laser, upon reaching a steady-state, had 
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heated the sample and so formed a ‘thermal lens’. Since then it has 
been widely used in a variety of measurements, including kinetics and 
reaction dynamics.37, 38 In 1973, Hu and Whinnery were able to 
demonstrate the detection of lens formation outside the laser cavity.39 
This opened the door to Swofford et al. who in 1976 employed a 
second laser to investigate the effect itself.40 Initially the thermal 
lensing effect was studied with a view to eliminate it due to 
interference observed in laser measurements.41 However, with the 
advent of affordable and increasingly efficient laser systems, the 
technique has been adapted for singlet delta oxygen measurements 
and the study of triplet states of photosensitising dyes.42, 43  
 
TRTL works on the principle of a sample, in solution or gas-phase, 
being excited by a focused pulsed laser of Gaussian profile, exhibiting 
the highest intensity in the centre compared to the wings. This non-
uniform excitation subsequently results in a temperature gradient due 
to the release of heat, a reflection of the energy absorbed by the 
sample, and so a temporal refractive index gradient is generated.23, 44 
The generation and decay of the temporary lens is monitored on a 
millisecond and microsecond timescale using a continuous wave laser, 
Before excitation by pulsed laser After excitation by pulsed laser 
Probe 
 
Beam 
Probe 
 
Beam 
 
Figure 3. 5. A simplified diagram illustrating the formation of the thermal lens and 
subsequent divergence of the probe beam after pulsed excitation. 
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as illustrated in Figure 3. 5. The transparency of the ground state and 
excited states of the sample species to the probe beam is key in the 
success of this technique, as any further absorption by transients can 
add to the thermal lensing effect in what is known as a population 
lens.45 
 
Throughout this work, TRPD is chosen technique by which ΦΔ are 
determined, using both PPN with ΦΔ = 0.9546 and ZnPc with 
ΦΔ = 0.6125 as the standards and 355 nm as the excitation wavelength. 
This was primarily due to the long accepted history and reliability of 
the technique. However, it was also hoped that construction of a 
TRTL spectrometer would yield a technique that would afford greater 
degrees of freedom in terms of experimental conditions and remove 
the dependence upon standards in the determination of ΦΔ values. 
With a view to this, a system was built that was rigorously tested 
using the same standards as TRPD before expanding to explore the 
experimental parameters available. 
3.3 Experimental Set-up – Construction of a Thermal 
Lensing Spectrometer 
A thorough search through literature revealed that the common core 
components of a TRTL spectrometer are: 
 A sample, 
 A focused pulsed ‘pump’ beam to excite sample, 
 A focused continuous wave ‘probe’ beam to monitor changes in 
sample, 
 Lenses to focus probe and pump beams, 
 Beamsplitter to make pump and probe beam collinear, 
 A filter before the detector to remove the pump beam, 
3.3 Experimental Set-up  
 49 
 Pinhole to select central area of the probe beam, 
 A detector and data collection system. 
 
A typical experimental set-up containing each of these components 
can be seen in Figure 3. 6. Traditionally the TRTL spectrometer has 
been constructed to include a Nd:YAG laser as the pulsed excitation 
source, and a HeNe laser as the cw probe.47 The pump beam and probe 
beam are aligned collinearly through the sample such that the probe 
beam can monitor the transient thermal lens formed following 
excitation. Perinaphthenone (PPN) was the standard used in TRPD 
measurements, it is soluble in a variety of solvents and has ΦΔ close to 
unity. The absorption spectrum is illustrated in Figure 3. 7 and shows 
the transparency of PPN to the probe beam at 632 nm. A similar 
spectrometer to those described in the literature was constructed in 
order to replicate and validate the technique using the calibration of a 
well-known standard. The components used will now be discussed in 
some detail. 
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Figure 3. 6. Schematic of a dual beam mode-mismatched thermal lens spectrometer 
illustrating the key components 
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3.3.1. Pump Beam 
The third-harmonic of a Q-switched Nd:YAG laser, 355 nm, was used 
as the excitation source. This replicates previous TRTL spectrometers 
and also the excitation source in the TRPD experiment used in this 
work. A CoSO4 filter was placed upstream from the sample in order to 
remove residual 1064 nm radiation. A 400 nm cut-off filter was placed 
upstream from the sample to remove residual 532 nm radiation. A 
repetition rate of 2 - 10 Hz was chosen to allow for full thermal 
relaxation of the sample between pulses. It must be noted that the 
Nd:YAG laser system was assembled with its associated dye-laser 
such that a variety of excitation wavelengths could be accessed and 
introduced into the set-up, if required. 
3.3.2. Probe Beam 
Initially a cw HeNe laser was used as the probe beam in order to 
replicate earlier set-ups. This was a success with PPN, however, 
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Figure 3. 7. A typical absorption spectrum of phenalenone, PPN. 
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significant modifications were required when considering the system 
for use with phthalocyanines. It is immediately evident that there is 
some significant absorption of the HeNe, at 632 nm, and a better 
approach would be to use an argon ion laser, 488 nm, where the 
phthalocyanine is transparent. Figure 3. 8 illustrates a typical 
absorption spectrum of a phthalocyanine and two available probe 
beams.  
3.3.3. Beamsplitter 
The fundamental element of the experiment is the relationship 
between the pulsed beam and probe beam relative to one another 
when the sample is irradiated. It is crucial that the beams are collinear 
through the sample. This was achieved using a series of pinholes both 
upstream and downstream from the sample, such that when the beams 
were combined at the point of the beamsplitter they were indeed 
collinear. The beamsplitter chosen for this spectrometer was a quartz 
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Figure 3. 8. A typical absorption spectrum of zinc phthalocyanine, ZnPc, illustrating 
absorption of the HeNe probe, λ = 632 nm, in the shoulder of the Q-band and 
transparency of the Ar ion probe, λ =  488 nm 
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wedge, which allowed the power of either the probe or pump, 
depending on the configuration, to be monitored during data collection. 
3.3.4. Lenses 
The arrangement of the focal points of the pump and probe beams was 
a fundamental point for consideration. There are two possible 
configurations of the focal points with respect to each other. The 
pump beam was focused into the centre of the cuvette and the probe 
beam was focused either at the front of the cuvette, leading to a large 
decrease in probe due to divergence of beam, or the back of the 
cuvette, leading to a large increase in probe due to convergence of 
beam, these are illustrated in Figure 3. 9.48 It was found that, using a 
lens of 100 mm focal length for Nd:YAG and a lens of 50 mm for 
HeNe, that a mode-mismatched configuration with HeNe focused 
before the Nd:YAG was the most sensitive and straightforward system 
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Figure 3. 9. Illustration of the dual beam mode-mismatched arrangements of pump beam 
relative to probe beam, with probe focussed before pump beam, top, and after pump 
beam, bottom, with the associated signals expected in each case. Purple lines represent 
pump beam. Full red line illustrates probe beam trajectory prior to lens formation, 
dashed red line represents probe beam trajectory following thermal lens formation. 
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possible with the space constraints presented. The same configuration 
was applied with success to the argon ion arrangement. 
3.3.5. Detection system 
The detection system comprises of a means to filter out the pump 
beam, a pinhole to select the very centre of the probe beam, a detector 
and a data collection system. Initially an iris was used to select the 
centre of the beam, however this was improved with the use of a 
pinhole with 300 μm diameter. Installation of a translation table 
provided the capacity to move the pinhole along the path of the probe 
beam into the far field in order to improve sensitivity.  
 
A monochromator was used to select the probe beam wavelength, 
which resulted in alterations made in the set-up with the change of 
probe beam. The detector provided an interesting challenge due to the 
fine balance between signal magnitude and sensitivity of the detection 
system. Initially a large area silicon photodiode coupled to a 2mΩ 
trans-impedance amplifier was used. However, it was realised after 
several experiments that a faster means of signal acquisition was 
required due to significant loss of data observed in the first 10 μs of 
the signal. Finally a photon multiplier tube was integrated into the set-
up, which gave a signal of good magnitude and reasonable S/N ratio 
with 200 scans. The data was recorded onto a two-channel digital real-
time oscilloscope.  
3.4 Data Collection 
Once the construction of the TRTL spectrometer had been completed 
the investigation of singlet delta oxygen quantum yield determination 
began. An air-saturated sample of PPN was prepared in a variety of 
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solvents and TRTL signal was maximized and traces collected. 
Initially PPN, which has ΦΔ of unity, was used to confirm the 
reliability of the spectrometer.  It was then necessary to explore and 
define the experimental conditions and protocol required for the 
determination of ΦΔ for the phthalocyanines. This required 
investigation into the impact and effect of solvent systems, power 
constraints and concentration limitations, which are discussed in detail 
in the results and discussion.  
3.5 Signal Analysis 
Figure 3. 10 illustrates snapshots taken from a video clip of the signal 
observed on an iris directly in front the detector and the full signal that 
was collected over the 0.1 s timescale. It is observed that a sudden 
appearance of the lens is reflected in a large decrease (a decrease in 
light intensity results in a positive deflection of the signal) in signal 
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Figure 3. 10. Plot of the growth and decay of the thermal lens on a millisecond timescale 
and the image of the probe beam on a pinhole placed before the detector, illustrating the 
blooming of the signal due to divergence from the formation of a transient lens. 
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intensity that relaxes by exponential decay back to the ground state as 
the heat dissipates through the solution. In order to acquire the desired 
information from the signal it is necessary to look on the microsecond 
timescale at the very formation of the lens to its maximum.  
 
A typical signal is shown in Figure 3. 11. It can be separated into two 
distinct parts that reflect the pathways on a molecular level. The fast 
portion of the signal is labelled as Uf and represents the relatively fast 
process of energy absorbed by the photosensitiser forming the S1 and 
T1 states and the subsequent quenching of the triplet state of the dye 
by molecular oxygen. This typically happens on a nanosecond 
timescale. The much slower part of the signal is referred to as US and 
is ascribed to the decay of the excited singlet oxygen state. This can be 
described mathematically as, 
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Figure 3. 11. Plot of the signal on a microsecond timescale, highlighting the fast and slow 
portions of the development of the lens. 
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and can be applied as a fit to the TRTL trace in order to determine Uf 
and Us. Once these parameters are known, the ratio of Us/UT can be 
used to determine ΦΔ as follows,49   
FFexT
s
EE
E
U
U



     (eq. 3. 7) 
Various reaction conditions have been investigated, in particular, 
those essential to determine the specific constraints of the reaction 
conditions required to obtain the most accurate values. 
3.6 Results and Discussion 
It was evident during construction of the thermal lensing spectrometer 
that absorption properties of the solute have a large role to play in 
defining the components to be used, in particular the pump and probe 
lasers. However, the degree of lensing due to singlet delta oxygen 
formation is exhibited through temperature changes in the solvent. It 
is generally accepted that the thermal lensing signal is largely 
dependent on the change in refractive index gradient relationship with 
change in temperature, dn/dT, as this determines the degree of lensing 
that will occur and subsequently the magnitude of signal due to the 
degree of divergence of the probe beam. Braslavsky and Heibel also 
suggest that the success of TRTL is highly dependent on the specific 
heat capacity, Cp, of the solvent and the thermal expansion coefficient, 
β.24 This was put to the test by investigating the thermal lensing traces 
generated by PPN in a variety of solvents with a range of thermal 
properties. All samples had absorbance of 0.1 at λ = 355 nm and all 
measurements were conducted under ambient conditions. It is 
immediately evident that both signal size and shape are entirely 
solvent dependent, as illustrated in Figure 3. 12. 
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Eq.3.6 was used to apply a mathematical fit to the data and identify 
the fast and slow portions of the signal. Analysis of the Us portion of 
the TRTL trace measured for each solvent provided the non-radiative 
lifetime of O2(1Δg), τΔ. These values can be seen in Table 3. 1 and 
compare well with literature values.50 Further analysis conducted on 
the magnitude of Ut showed that in comparison with β/Cp and dη/dT, 
see Figure 3. 13, these properties were key in determining whether 
TRTL would work 
successfully in a given 
sample or not. With this 
information it is obvious that 
water is a difficult medium to 
measure ΦΔ values in, due 
both to the short O2(1Δg) 
lifetimes and relatively low 
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Figure 3. 12. TRTL traces illustrating the difference in magnitude of signal depending on 
the solvent with samples of A = 0.1 at λ = 355 nm. 
 
Solvent τΔa (μs) τΔb (μs) 
Water 4 20 – 4 
Methanol 10.7 9.6 – 12 
Ethanol 12.2 9.6 – 19 
Propan-2-ol 15.4 16 – 18 
Acetone 30 40 – 55 
Toluene 27.3 29 
Table 3. 1. Radiative lifetimes of singlet delta 
oxygen as determined by TRTL, a, and found 
in literature, b. 
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heat capacity and thermal expansion 
coefficient, when compared with other systems. It can also be 
predicted that the toluene/pyridine solvent system used in determining 
phthalocyanine results should be favourable in this sense. 
 
A number of experiments were performed in order to determine a 
working protocol and set of experimental parameters, in particular 
those exploring the range of excitation laser power and sample 
concentration. The results of these preliminary tests are illustrated in 
Figure 3. 14 and show that the signals obey a linear relationship when 
absorbance at the excitation wavelength is less than 0.1 and power is 
less than 2 mJ. 
 
Finally, it is hoped that the technique can be applied to the 
determination of triplet state properties of these molecules. This is a 
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Figure 3. 13. Plots of key solvent properties with respect to magnitude of thermal lensing 
signal. 
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difficult area to measure for phthalocyanines due to the requirement of  
detectors that are capable of picking up weak phosphorescence signals 
in the near-IR range. For that reason quenching methods are often 
used to define triplet energies by defining a range in which the triplet 
state lies. In the case of TRTL, once the solutions are degassed and 
oxygen is no longer quenching the triplet state, the slow part of the 
signal, Us, can be identified as the decay of the triplet state of the 
photosensitiser. Eq.3.6 can still be used to determine Us and Uf, but 
now equation 7 becomes, 
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Figure 3. 14. Plots illustrating the relationship between Us and Ut and power , top, and 
concentration, bottom. 
3.6 Results and Discussion  
 60 
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T ex F F
U E
U E E

      (eq. 3. 8) 
Hence, if ET is known then ΦT can be determined and vice versa. In 
the case of this study the ΦT were determined by an alternative 
method so an approximate value of ET could be calculated.45  
 
A degassed sample of PPN was prepared by the freeze-pump-thaw 
method and a TRTL trace collected, see Figure 3. 15. From the data a 
triplet energy of 220 kJ mol-1 was determined.  
3.7 Conclusion 
To conclude, it is believed that a viable system has been constructed 
for the purpose of singlet delta oxygen quantum yield determination. 
However, the system also has the potential to investigate 
phthalocyanine dyes further in terms of elucidating the necessary 
triplet data, which can often be difficult to do. 
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Figure 3. 15. Triplet thermal lensing signal of PPN in 1% toluene/pyridine 
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4. Silicon Phthalocyanine Derivatives 
4.1 Introduction 
The past three decades have played witness to an explosion of interest 
in the research of silicon phthalocyanine derivatives.1-4 These 
compounds have proved hugely successful in both in vitro and in vivo 
studies as sensitizers for phototherapies in dermatological conditions,5 
fungal infections,6 oncology7 and HIV.8 One of the most successful 
silicon phthalocyanine compounds to progress to clinical trials is Pc 4, 
a silicon-based hydrophobic phthalocyanine containing an axial 
aminosiloxy ligand, Figure 4.1 structure f.5, 10-12 Pc 4 has a number of 
advantageous properties including high molar extinction coefficient, 
2 x 10-5 M cm-1, maximum Q-band absorption at 675 nm and singlet 
delta oxygen quantum yields of 0.43.3 The defining modification in 
this molecule is the axial substitution, which is considered to 
significantly enhance the solubility of the compound. Nevertheless, a 
key disadvantage associated with the Pc 4 molecule is the tedious and 
lengthy synthesis, which hampers chemical modifications and 
subsequent investigations into the structure-activity relationship.7, 13 
 
Previous research has predominantly focused on the influence of axial 
modification, Figure 4.1, with a view to synthesizing amphiphilic 
phthalocyanines with a high cellular uptake.14, 15 These compounds 
have proven to have enhanced photodynamic activity in in vivo studies 
compared to analogous compounds with limited solubility in aqueous 
and lipid environments.16 However, such research also indicates that 
there is limited impact upon photophysical and photochemical 
properties using axial modifications, with triplet and singlet oxygen
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Figure 4. 1. Schematic diagram of a variety of axial modifications applied to silicon 
phthalocyanine. 
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quantum yields remaining low, 
as illustrated in Table 4.1. The 
limited research performed on 
substitution of the benzenoid 
rings in either the alpha or beta 
position has indicated that there 
is opportunity for significant 
tuning of desired singlet and 
triplet state properties in
similar ways that have been 
achieved for other 
phthalocyanines.17, 18 The 
research herein is centred on the 
influence of octa-alpha substitution of alkyl chains on the benzenoid 
rings in order to enhance both solubility and the required properties 
for photodynamic therapy. 
4.2 Results and Discussion 
4.2.1 Spectroscopic data 
The absorption spectra of silicon phthalocyanine hydroxide, 6SiPc and 
8SiPc can be seen in Figure 4.2. All absorption spectra fall well within 
the desired optical window of 650 – 800 nm and exhibit the typical 
shape of phthalocyanines.19 The sharp Q-band at 710 nm is an 
indication that there is no aggregation occurring in solution. This is 
due to hydroxide substitution in the axial position, which prevents 
aggregation that is commonly accepted to be brought about by π-π 
stacking.20 Upon substitution of alkyl groups in the alpha position, the 
absorption spectra of the substituted silicon phthalocyanine 
Compound ΦΔ τT / μs Solvent Ref. 
Cl2SiPc 0.37  CHCl3 1 
(OH)2SiPc 0.28  DMSO 2 
a  243 THF 1 
 0.32  CHCl3 1 
b  213 THF 1 
 0.35  CHCl3 1 
c 0.20  DMF 4 
d 0.50 139 Acetonitrile 3 
e 0.20 188 Acetonitrile 3 
f 0.43 113 CH3CN 3 
g 0.32 160 CH3CN 3 
h (n = 1) 0.392   9 
h (n = 2) 0.35  MeOH 9 
h (n = 3) 0.37  MeOH 9 
h (n = 4) 0.371  MeOH 9 
h (n = 5) 0.375  MeOH 9 
h (n = 6) 0.384  MeOH 9 
Table 4. 1. Summary of axially modified 
silicon phthalocyanine compounds with 
triplet lifetimes, τT, and singlet delta oxygen 
quantum yields, ΦΔ. 
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compounds exhibit a broadening of the Q-band, which is suggestive of 
a minor change in structure. This is an expected outcome due to steric
hinderance brought about by the nature and position of the long alkyl 
chains on the benzenoid ring. A bathochromic shift of 18 nm is also 
observed for both compounds relative to the parent compound, which 
exhibits a Q-band maximum at 692 nm, and is attributed to the 
electron-donating nature of the alkyl groups, which causes a reduction 
of the HOMO – LUMO gap. This has been previously observed in 
other phthalocyanines that bear different metal centres.21-23 
Substitution of the alkyl groups also affords this set of compounds 
improved solubility in a number of solvents including water and 
ethanol compared to the parent compound, which exhibits no 
solubility in either solvent. This is a significant development in the 
pursuit of new photosensitizers in photodynamic therapy. In silicon 
phthalocyanine systems improved solubility is typically associated
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Figure 4. 2. Absorption spectra for silicon phthalocyanine derivatives. 
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with axial modification, due to a reduction in the propensity towards 
aggregation. However, it is widely recognized in other 
metallophthalocyanine systems that octa-substitution of long chains 
enhances solubility in both organic and aqueous environments, which 
is the case in this example as both substituted compound and parent 
compound contain identical axial substituents.24  
 
Emission and excitation spectra for the substituted silicon 
phthalocyanine compounds are similar, Figure 4.3, with maximum 
emission at 716 nm for the substituted compounds compared to 
704 nm for the parent. Unlike the parent compound, where some 
broadening of the emission is observed, the emission is the mirror 
image of the absorption. This is a strong indication that the structure 
does not undergo major distortion upon excitation. 
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Figure 4. 3. Emission and excitation data of SiPc (left) and 6SiPc (right). 
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4.2.2 Photophysics 
Fluorescence lifetimes determined using time-correlated single photon 
counting are 3.8 ns for both 6SiPc and 8SiPc, which are in the 
expected range for these compounds. An example of a typical decay is 
given in Figure 4.4. Fluorescence quantum yields were determined to 
be 0.27, compared to 0.18 of the parent compound, and are also well 
within the range expected for silicon phthalocyanine compounds. 
 
The transient absorption spectra of the parent compound and 
substituted compounds are similar and typical examples can be seen in 
Figure 4.5. The spectra show a broad band between 400 – 600 nm 
with a peak at 552 nm. Triplet decays were determined by fitting an 
exponential to the decay of transient absorption at 530 nm and 552 nm 
for SiPc and nSiPc respectively to give lifetimes of 103 μs and 160 μs 
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Figure 4. 4. Typical fluorescence signal decay with fit measured at 720 nm. The lighter 
line indicates the instrument response function. The decay is shown on a linear scale in 
the inset. 
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respectively. It can be seen that the effect of alkyl substitution is a 
longer triplet lifetime, a highly desired property for photodynamic 
therapy. Triplet quantum yields were found to be 0.53 and 0.55 for 
6SiPc and 8SiPc respectively. These are substantially larger than those 
typically found for silicon phthalocyanine compounds and suggests 
that alpha-substitution of an electron-donating group promotes spin-
forbidden intersystem crossing from the excited singlet state to the 
triplet state. 
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Figure 4. 5 Transient triplet-triplet absorption spectrum of SiPc (top) and 6SiPc (bottom) 
in 1% v/v pyridine/toluene at 1 x 10-5 M, λex = 355 nm. The broad absorption with peak 
observed between 400 – 600 nm is due to T-T* absorption. 
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4.2.3 Photochemistry 
The final parameter to be quantified is the singlet delta oxygen 
quantum yield. Literature values of SiPc in DMSO present ΦΔ = 0.28. 
Through time-resolved singlet oxygen phosphorescence detection this 
work has determined that 6SiPc and 8SiPc both have ΦΔ values of 
0.49 in 1% v/v pyridine/toluene. Furthermore, due to the solubility of 
these compounds in aqueous media it was considered viable to 
measure the same parameter in ethanol and water. As has previously 
been discussed, it is notoriously difficult to determine ΦΔ in water due 
to the fast non-radiative lifetimes, which are typically in the region of 
3 – 5 μs. However, provisional signals using the time-resolved thermal 
lensing technique has afforded results for ethanol show ΦΔ for 8SiPc 
to be 0.48, Figure 4.6. This is a promising results as previous solvent 
studies conducted by Nyokong et al. on substituted zinc 
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Figure 4. 6 Time-resolved thermal lensing signal of 8SiPc in 1% v/v pyridine/toluene 
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phthalocyanine compounds have often indicated that observed ΦΔ 
values in protic solvents such as water and methanol are typically 
determined to be lower due to the deactivation of singlet oxygen by 
these solvents.25 It has also been observed that the substituted silicon 
phthalocyanine compounds have high SΔ values of 0.94 and 0.95 for 
6SiPc and 8SiPc, respectively. This means that of the triplet states 
produced a large proportion is successfully quenched by molecular 
oxygen to generate singlet delta oxygen, the cytotoxic agent required 
in photodynamic therapy to induce cell death. 
4.3 Conclusion 
To conclude, it has been revealed that there is significant enhancement 
of several key properties of silicon phthalocyanine as a consequence 
of alpha alkyl substitution. These include the enhancement of 
solubility in aqueous and organic environments, fulfilling the 
requirements of amphiphilicity, a red-shift of the Q-band from 694 nm 
to 710 nm, hence deeper skin penetration, longer triplet lifetimes and 
improved triplet quantum yields resulting in an enhancement of the 
triplet state population and subsequently an improved singlet oxygen 
quantum yields. Though there is little to no discernable difference, 
within error, between the substituted compounds when comparing 
chain length of the alkyl substituent, both compounds have enhanced 
properties that make for promising candidates for in vivo studies and 
clinical trials. 
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5. Zinc Phthalocyanine Derivatives 
5.1 Introduction 
Over the past 40 years there has been a great interest in investigating 
the diverse application of phthalocyanines, and in particular zinc 
phthalocyanines. As has previously been discussed, these compounds 
have real potential as photosensitisers in photodynamic therapy, PDT. 
However, there is also a great interest surrounding zinc 
phthalocyanine, ZnPc, for application in photochemical cells, optical 
discs, solar cells and nonlinear optical limiting devices.1-4 
Consequently, there has been much research conducted on optimising 
the properties of ZnPc.5, 6 Zinc phthalocyanine has a maximum 
absorption of 670 nm, with extinction coefficient in the region of 
3 x 10-5 M cm-1, high triplet quantum yield (ΦT = 0.6), high singlet 
delta oxygen quantum yield (ΦΔ = 0.58) and is known to exhibit 
strong photobiological activity against tumours.7 One of the key 
advantages of this compound is the opportunity afforded to fine-
tuning the structure by incorporation of substituents on the benzenoid 
rings. Addition of substituents in the alpha (1, 4) and beta (2, 3) 
position can have a marked influence on the physical, photophysical 
and photochemical properties.8, 9 Both the number of substituents 
introduced and the electronic nature of the substituent can be used to 
optimise the desired characteristics of the molecule. Table 5.1 
provides a summary of a selection of zinc phthalocyanine based 
compounds studied to date containing either electron withdrawing 
groups or electron donating groups and includes some key 
photophysical and photochemical properties. 
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R Position No. of subs λmax / nm λem / nm Φf ΦT ΦΔ Solvent Ref. 
-H  16 670 676      
Electron-withdrawing groups 
          
-F α + β 16 670      10 
 α + β 16 638 688 0.21    11 
-I β  4 680  0.088 0.86 0.54 DMSO 12 
-Br β  4 676  0.17 0.76 0.41 DMSO 12 
-Cl β  4 672  0.29 0.59 0.35 DMSO 12 
-Cl β  8 683  0.02  0.34 DMSO 13 
-NO2 β  4 682  0.12  0.24 DMF 13 
-SO3 β  4 680    0.28 DMSO 13 
-SO3H β  4 680      14 
-COOH β  4 680    0.48 DMF/pyridine 
14 
-COOH β 4 685      10 
-COOH β  8 684    0.52 pH10  
-CN β 8 671      10 
-SO2Ph α 4 664 720 0.038    9 
 β  4 676.7 686 0.397    9 
-SO2Ph/-tBu α/β 4/4 668.4 678.5 0.441    9 
-NO2 α 4 671 683 0.23    15 
-NO2 α 4 669.2 678 0.488    9 
 β  4 671.0 695 0.159    9 
-NO2/-NO2 α/β 4/4 674 698 0.088    9 
          
Electron-donating groups 
-SPh/-t-Bu α/β 4/4 709.5 727.4 0.224    9 
-SPh β  4 680 694 0.14    11 
-SPh α 4 706.7 687.5 0.276    9 
 β  4 684.5 687.5 0.439    9 
 β  8 707.8 721.2 0.090    9 
-S-C6H4CH3 β  8 715    0.52 DMF 16 
-S-C4H9 β  8 708    0.61 DMF 16 
-Sbu α 4 708.6 718.2 0.137    9 
 β  4 687.4 685 0.386    9 
 α 8 779.6 781 0.036    9 
 β  8 707.0 733 0.119    9 
-O-Ph  8 687 687   0.60  16 
-O-Ph-CH3 β  8 679  0.24 0.63 0.51 DMSO 13 
-O-Ph-C(CH3)3 β  4 681    0.55 DMF 12 
-O-Ph-C(CH3)3 β  4 680      13 
-O-Ph-
CH2CH2COOH 
α 4 695 708    DMF  
 β  4 679 686    DMF  
Table 5. 1. Summary of zinc phthalocyanine compounds with absorption, emission, 
fluorescence, triplet and singlet oxygen data, where available. 
5.1 Introduction 
 77 
 
Previous reviews indicate that the addition of strongly electron 
donating groups result in a large red shift in absorption while addition 
of electron withdrawing groups has a much smaller influence on 
absorption shift. Other observations show that tetra or octa-
substitution in the beta position aids solubilisation of phthalocyanines 
much more than the equivalent substitution in the alpha position.18 
 
Herein we will examine a series of alpha octa-alkyl zinc 
phthalocyanines (n = 1, 5 – 10, 12 and 15) and ZnTBTAP (n = 6), see 
Figure 5.2. Originally these compounds were synthesised as part of a 
study into the liquid crystal properties associated with molecules with 
long alkyl chains.19, 20 This proved that alkyl chains attached to the 
phthalocyanine nucleus at alpha sites leads to mesophase formation.21 
However, the potential as photosensitisers was soon recognised and 
R Position No. of subs λmax / nm λem / nm Φf ΦT ΦΔ Solvent Ref. 
-O-Ph-COOH α 4 686 698    DMF  
 β  4 674 685    DMF  
-O-Ph-COOC4H9 α 4 687 696    DMF  
 β  4 675 685    DMF  
-CH3 α 8 696      17 
-t-Bu β  4 675      10 
-OiPr α 4 702 724 0.22    15 
-C(CH3)3 β  4 691 712 0.11    11 
-OCH2CF3  16 707 716 0.0745     
-
OCH2CH2CH2CH3 
α 8 748 - -    11 
-OCH2(CH2)6CH3 β  8 690 706 0.10    11 
-NH2 α 4 765 790 0.001    15 
 β  4 725 756 0.004    15 
-Obu α 4 696 706 0.143    9 
 β  4 674.5 689 0.422    9 
 α 8 758 807.5 0.062    9 
 β  8 674.5 681.5 0.616    9 
-Obu β  8 674      10 
 α 8 739      10 
  16 714      10 
-OC6H13 β  8 740    0.52 DMF 14 
Table 5. 1. (cont.) Summary of zinc phthalocyanine compounds with absorption, emission, 
fluorescence, triplet and singlet oxygen data, where available. 
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this series of compounds will be investigated with a view to 
determining the photophysical and photochemical parameters and 
comparing with other similarly related structures. 
5.2 Results and Discussion 
5.2.1 Spectroscopic data 
The absorption spectra of the parent compound, 1ZnPc, 6ZnPc and 
6ZnTBTAP can be seen in Figure 5.2. All absorption spectra are in the 
desired optical window of 650 – 800 nm and are typical of other 
phthalocyanines. It is clear to see that any substitution in the alpha 
position results in a red-shift of the Q-band maxima with some 
broadening of the band, but little influence on the shape of the 
absorption.8 This is suggestive of a small disruption of the structure as 
a result of the addition of long alkyl chains and can be assigned to a 
steric factor. This has been previously observed in analogous H2Pc 
structures whereby the crystal structure of octaisopentyl and octahexyl 
substituted H2Pc, 5H2Pc and 6H2PC respectively, showed that the 
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Figure 5. 1. Schematic diagram of the zinc phthalocyanine derivatives studied. 
Where  X = N, R = CH3 1ZnPc 
 X = N, R = C5H11 5ZnPc 
 X = N, R = C6H13 6ZnPc 
X = N, R = C7H15 7ZnPc 
X = N, R = C8H17 8ZnPc 
X = N, R = C9H19 9ZnPc 
X = N, R = C10H21 10ZnPc 
X = N, R = C12H25 12ZnPc 
X = N, R = C15H31 15ZnPc 
 
X = CH, R = C6H13 6ZnTBTAP 
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substitution led to some distortion from planar to a saddle shape 
structure.22, 23 The red-shift of the Q-band has been attributed to the 
substitution of the alkyl group in the alpha position. This has 
previously been observed in zinc phthalocyanines with alkyl, thioalkyl 
and alkoxy groups in the alpha position and is ascribed to the electron-
donating nature of these groups.24 Analysis of the shift of the Q-band 
maxima relative to the length of the alkyl substituent indicates a 
positive correlation between the two components, which reaches a 
maximum at 3 carbons. This is similar to previously studied zinc 
alkoxy substituted systems, which also reach maximum shift at chain 
length of 3 carbons.25 
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Figure 5. 2. Absorption spectra of zinc phthalocyanines (top) and derivatives, from top to 
bottom, 1ZnPc, 6ZnPc and 6ZnTBTAP 
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Absorption maxima of the Q-band of a number of substituted 
compounds has been plotted relative to the Hammett substituent 
constant in order to determine whether there is a relationship between 
the magnitude and nature of the shift relative to the electronic 
properties of the substituent, Figure 5.3. It is clear to see that there is a 
more pronounced red-shift of the Q-band with electron-donating 
groups, which have more negative Hammett substituent constants. 
Previous density functional theory studies on the effect of peripheral 
substitution have shown that the introduction of tetra- or octa-
substitution of electron-donating groups in the alpha position, where 
the HOMO has a large amplitude, results in an effective upward shift 
of the orbital and, therefore, in a diminished HOMO – LUMO gap.26, 
27 This is in contrast to substitution at the beta position where the 
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Figure 5. 3. Comparison of the compound Hammett substituent constant, σp, of 
substituent with respective shift of the Q-band relative to the position on the benzenoid 
ring. 
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HOMO has relatively small amplitude, hence the influence of any 
group substituted into this position is significantly reduced with 
respect to the parent compound.  
 
The absorption spectra of 6ZnTBTAP exhibits a blue-shift of the 
Q-band compared to 6ZnPc, Figure 5.2. As with previously published 
research on MgTBTAP and H2TBTAP analogues, the doubling of the 
Q-band and blue shift is expected due to the change in symmetry from 
D4h symmetry, as exhibited by the analogous phthalocyanine, to D2h.23, 
28 
 
Emission and excitation spectra for the zinc compounds are similar, 
Figure 5.4, though substituted ZnPc compounds with alkyl chain 
length greater than 5 carbons seem to exhibit a significant broadening 
of the emission spectra, this may be attributed to a change in structure 
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Figure 5. 4. Emission and excitation data of the zinc phthalocyanine derivatitves. 
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of the molecule upon excitation. All exhibit a Stokes shift in the range 
10 – 20 nm. 6ZnTBTAP has a modified emission spectra, with a loss 
of the shoulder, but no broadening is observed. 
5.2.2 Photophysics 
The fluorescence lifetimes have been summarised in Table 5.2. It can 
be seen that the lifetimes are short, 2.5 ns and 1.8 ns for 1ZnPc and 
nZnPc, where n > 5, respectively compared to 3.1 ns for ZnPc. The 
fluorescence quantum yields of the compounds are also further 
reduced upon substitution, 0.16 and 0.12 for 1ZnPc and nZnPc 
respectively compared with 0.34 for ZnPc in 1% v/v pyridine/toluene. 
This follows in the observed trend and is indicative that alkyl 
substitution goes some way in promoting intersystem crossing from 
the excited state to the triplet state. The fluorescence lifetime for 
6ZnTBTAP was determined to be 1.3 ns and fluorescence quantum 
yield was found to be 0.06. Both values are significantly smaller than 
the analogous phthalocyanine, 6ZnPc. The transient absorption spectra 
of all compounds were similar in shape and examples can be seen in 
Figure 5.5. The spectra are typical of the series and all show a broad 
Compound λQ / nm εs / 105 M-1cm-1 λf / nm τf / ns ΦF kf / 107 s-1 
       
ZnPca 671 2.8  676 3.1 0.34 11 
1ZnPc 694 2.6 ± 0.2 704 2.5 ± 0.1 0.16 ± 0.02 6.4 
2ZnPcb 696 - - - - - 
3ZnPcb 702 - - - - - 
4ZnPcb 703 - - - - - 
5ZnPc 704 1.8 ± 0.2 718 1.8 ± 0.1 0.12 ± 0.02 6.67 
6ZnPc 704 1.8 ± 0.2 718 1.8 ± 0.1 0.12 ± 0.02 6.67 
7ZnPc 704 1.8 ± 0.2 718 1.8 ± 0.1 0.12 ± 0.02 6.67 
8ZnPc 704 1.8 ± 0.2 718 1.8 ± 0.1 0.12 ± 0.02 6.67 
9ZnPc 704 1.8 ± 0.2 718 1.8 ± 0.1 0.12 ± 0.02 6.67 
10ZnPc 704 1.8 ± 0.2 718 1.8 ± 0.1 0.12 ± 0.02 6.67 
12ZnPc 704 1.8 ± 0.2 718 1.8 ± 0.1 0.12 ± 0.02 6.67 
15ZnPc 704 1.8 ± 0.2 718 1.8 ± 0.1 0.12 ± 0.02 6.67 
6ZnTBTAP 698, 674 1.3 ± 0.2 703 1.6 ± 0.1 0.06 ± 0.02 3.75 
Table 5. 2. Photophysical properties of the alpha substituted zinc phthalocyanines and 
derivatives. 
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peak between 400 – 600 nm with peaks for ZnPc, 1ZnPc, and 6ZnPc 
at 480, 520, and 534 nm respectively. Triplet decays were determined 
by fitting an exponential to the decay of transient absorption measured 
at the respective maxima and gave values of 113 μs and 50 μs for 
1ZnPc and nZnPc respectively. Such triplet lifetimes are in the range 
expected of zinc phthalocyanines, though are significantly shorter than 
the parent compound, which has triplet lifetime of 300 μs. Triplet 
extinction coefficients were determined to be in the range 2.6 – 3.1 x 
104 M-1 cm-1 and were used to calculate the triplet quantum yields 
which were are in the range 0.63 – 0.84 and are also summarized in 
Table 5.3. The transient absorption spectrum for 6ZnTBTAP shows a 
broad peak with maximum wavelength at 520 nm, and triplet lifetimes 
were determined to be 381 μs, with triplet absorption coefficient of 
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Figure 5. 5. Transient triplet-triplet absorption of ZnPc, 1ZnPc, 6ZnPc and 6ZnTBTAP 
in toluene-pyridine at 1 x 10-5 M, excitation wavelength 355 nm. The broad absorption 
with peak observed between 400 – 600 nm is due to T-T* absorption. 
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1.7 x 104 M-1 cm-1 and triplet quantum yield of 0.78, similar to the 
phthalocyanine counterpart. 
 
The observed decrease in the fluorescence quantum yield in all 
compounds studied is complemented by an increase in the triplet 
quantum yield. It can be seen that the influence of alkyl alpha 
substitution on the orbitals of the phthalocyanine molecule has an 
impact on the fluorescence and triplet properties of the molecules. 
 
In the absence of other processes the data presented above would 
suggest that the fluorescence transition gets progressively more 
intense with increasing chain length of the alkyl substituent. However, 
it can also be concluded that intersystem-crossing competes more 
effectively with fluorescence in compounds with chain length 5 – 15 
compared to the parent compound and 1ZnPc as the triplet quantum 
yields are higher. From the quantum yields it can be seen that the 
fluorescence and intersystem-crossing are the dominant processes 
such that ΦF + ΦT ≈ 1. Hence, we are able to express the fluorescence 
quantum yield as: 
Compound τT / μs T-Tmax / nm 
Δε / 104
M-1cm-1 ΦT ΦΔ SΔ = ΦΔ/ΦT 
       
ZnPc 330 480 3.4 0.65 0.58 0.89 
1ZnPc 113 ± 5 530 ± 10 3.1 ± 0.2 0.63 ± 0.07 0.54 ± 0.05 0.85 
5ZnPc 56 ± 5 534 ± 10 3.0 ± 0.2 0.78 ± 0.07 0.71 ± 0.05 0.91 
6ZnPc 51 ± 5 534 ± 10 2.8 ± 0.2 0.84 ± 0.07 0.73 ± 0.05 0.87 
7ZnPc 52 ± 5 534 ± 10 3.1 ± 0.2 0.84 ± 0.07 0.72 ± 0.05 0.86 
8ZnPc 50 ± 5 534 ± 10 2.6 ± 0.2 0.81 ± 0.07 0.71 ± 0.05 0.88 
9ZnPc 56 ± 5 534 ± 10 2.8 ± 0.2 0.82 ± 0.07 0.67 ± 0.05 0.82 
10ZnPc 58 ± 5 534 ± 10 2.6 ± 0.2 0.82 ± 0.07 0.68 ± 0.05 0.83 
12ZnPc 60 ± 5 534 ± 10 2.6 ± 0.2 0.82 ± 0.07 0.67 ± 0.05 0.82 
15ZnPc 58 ± 5 534 ± 10 3.1 ± 0.2 0.82 ± 0.07 0.65 ± 0.05 0.80 
6ZnTBTAP 380 ± 5 520 ± 10 1.7 ± 0.2 0.78 ± 0.07   
Table 5. 3. Triplet and photochemical properties of alpha substituted zinc 
phthalocyanines and derivatives. 
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ISCF
F
F kk
k
  
Where, kF is the radiative rate constant, which is expressed as: 
F
F
Fk 
  
And kISC is the rate of intersystem crossing. Using ΦF = 0.34 and the 
measured value of τF = 3.1 x 10-9 s-1 we obtain kF = 1.1 x 108 s-1 and 
kISC = 2.3 x 108 s-1. The methine substituted phthalocyanine and nZnPc 
also have ΦF + ΦT ≈ 1, hence, the same calculations can be carried out 
and the values obtained are kF = 6.4 x 107 s-1 and 6.67 x 107 s-1 and 
kISC = 3.36 x 108 s-1 and 4.89 x 108 s-1 for 1ZnPc and nZnPc 
respectively. 
 
Intersystem crossing in both 1ZnPc and nZnPc are 1.5 and 2.1 times 
as fast as in the parent compound. The only difference in these 
compounds is the alkyl substitution in the alpha position. This 
coincides with previous analysis that the difference in intersystem 
crossing rates may be attributed to a relative shift in energies between 
the S1 and T1 states upon alpha substitution. The maximum absorption 
of ZnPc is at 671 nm (14,900 cm-1) and the triplet absorption has its 
maximum at 1092 nm (9160 cm-1). The intersystem crossing rate of 
1ZnPc is one and a half that of ZnPc and for nZnPc is twice that of 
ZnPc which implies that there is a smaller energy gap between S1 and 
T1 in both cases. If it is assumed that the rate is inversely proportional 
to the energy difference an estimate of the phosphorescence 
wavelength can be calculated. The absorption wavelength of 1ZnPc is 
694 nm (14409 cm-1) and taking two thirds the energy difference in 
ZnPc the phosphorescence wavelength maximum is estimated as 
945 nm (10582 cm-1). The absorption wavelength of nZnPc is 704 nm 
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(14205 cm-1) and taking half the energy difference in ZnPc an estimate 
of the phosphorescence wavelength maximum is determined to be 
871 nm (11472 cm-1). 
 
Using time-resolved thermal lensing techniques it was possible to 
determine provisional data that suggests the triplet energy of 5ZnPc to 
be approximately 130 kJ mol-1, a typical signal including the fit is 
shown in Figure 5.6. This is largerr than the documented value of 
110 kJ mol-1 for ZnPc and would agree with the data presented in this 
report.29 
5.2.3 Photochemistry 
A necessary requirement of photodynamic therapy is a relatively high 
absolute quantum yield of oxygen, specifically ΦΔ > 0.5. The results 
are summarised in Table 5.3, where it can be seen that the values are 
as expected. Given previous fluorescence and triplet data determined 
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Figure 5. 6. Time-resolve thermal lensing signal of a degassed sample of 5ZnPc in 1% v/v 
pyridine/toluene at 1 x 10-5 M, excitation wavelength 355 nm. 
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for each of the compounds, it can be predicted that ΦΔ will be a 
reflection of the triplet state, which is indeed the case. The reduction 
in triplet quantum yield of 1ZnPc is mirrored in a reduced ΦΔ = 0.54, 
compared to ZnPc with ΦΔ = 0.58 and nZnPc in the range ΦΔ = 0.65 – 
0.73. SΔ values, which are a ratio of singlet oxygen quantum yields to 
triplet quantum yields, show all compounds behave in a similar way 
with values of 0.89, 0.85 and 0.80 – 0.91 for ZnPc, 1ZnPc and nZnPc, 
respectively. Though it has not been possible to collect the singlet 
delta oxygen values of 6ZnTBTAP it can be predicted, given the 
trends observed for the analogous 6ZnPc species, that if SΔ values fall 
in the range 0.80 – 0.90 then ΦΔ will be in the range 0.62 – 0.70. 
5.3 Conclusion 
In conclusion, it has been shown that the series of zinc 
phthalocyanines and zinc triazabenzoporphyrin form a promising 
group of candidates as photosensitisers. The addition of alkyl chains 
in the alpha position of the benzenoid rings results in a red-shift of the 
Q-band, diminished fluorescence quantum yield and enhanced triplet 
quantum yield compared with the parent compound. This is a 
desirable property for photosensitisers as it equates to an efficient 
transfer of energy to the desired states. This leads to achieving the 
ultimate goal of high singlet delta oxygen quantum yields.  In addition 
to modification of the alkyl substituents, the analogous 6ZnTBTAP 
compound also proves favourable in terms of a photosensitizing 
compound. Though, results are slightly lower than the analogous 
6ZnPc, they are still significantly higher than the parent compound 
and also have the benefit of a far longer triplet state lifetime than 
6ZnPc.  
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6. Palladium Phthalocyanine Derivatives 
6.1 Introduction 
There is a distinct lack of literature concerning 
metallophthalocyanines with open-shell metals such as platinum and 
palladium compared to diamagnetic systems such as zinc, aluminium 
and copper.1-4 Table 6.1 highlights the compounds that have been 
synthesised and characterised to date with respect to possible 
application as photosensitisers in phototherapies. It can be seen that a 
key property of these compounds is the short triplet lifetime. Short 
lifetimes are fundamentally an undesirable property for any potential 
photosensitizer as it indicates that the electronically excited state 
decays preferentially by non-radiative pathways, releasing the 
absorbed energy as heat. This feature in itself has prompted a burst in 
research in the direction of photothermal therapy.7, 8 Photothermal 
therapy works using similar principles to photodynamic therapy. By 
R Sol 
λmax / 
nm 
Log ε λem / nm ΦF 
λT-T* / 
nm 
ΦT τΔ / μs ΦΔ 
-H1  660  664 0.0005 620  25  
-OC6H52 1-CNP 668 5.11    0.51 23 0.49 
-OC6H4OC6H52 1-CNP 670 5.25 682 < 0.01  0.65 20 0.43 
-SC5H135 1-CNP 698  745 < 0.01  0.47 15 0.42 
-SC8H175 1-CNP 698  707 < 0.01  0.42 12 0.40 
-SC12H256 1-CNP 698  707 < 0.01  0.40 10 0.39 
-OBu9 DMF 722 5.6 734 0.0008  0.77 3.04  
Table 6. 1. Summary of palladium phthalocyanine compounds with absorption, emission, 
fluorescence, triplet and singlet delta oxygen quantum yields, where available. 
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applying a combination of light and photosensitiser to treat damaged 
cells, rather than producing cytotoxic oxygen to induce cell death, the 
technique centres around the localized production of heat, which 
results in damage to cells and, ultimately, cell death.10 
 
In 2003 Cook et al.11 published the synthesis of a series of 
octaalkylphthalocyanines, including palladium, with respect to non-
linear absorption properties for application in optical limiters. It was 
found that the palladium derivatives exhibited the strongest non-linear 
absorption of the series of compounds studied. The successful 
synthesis of 6PdPc and subsequently 8PdPc, see Figure 6.1, has paved 
the opportunity to further explore this family of heavy-metal 
compounds for their potential application as photosensitizers in 
photodynamic therapy. 
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Figure 6. 1. Schematic diagram of the palladium phthalocyanine derivatives studied. 
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6.2 Results and Discussion 
6.2.1 Spectroscopic data 
The absorption spectra of 6PdPc and 8PdPc can be seen in Figure 6.2. 
No absorption spectrum was available for the parent compound. 
However, literature values show palladium phthalocyanine to have a 
Q-band maxima at 664 nm compared to the substituted compounds at 
690 nm, a red-shift of 26 nm into the therapeutic window, 650 –
 800 nm.1 This is attributed to the substitution of electron donating 
groups in the alpha position, which induces a reduction of the HOMO 
– LUMO distance. Both compounds exhibit the typical shape for 
300 400 500 600 700 800
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
A
bs
or
ba
nc
e
Wavelength / nm
 8PdPc
 6PdPc
 
Figure 6. 2. Absorption spectra of palladium phthalocyanine derivatives. 
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standard absorption spectra, indicating no change in symmetry upon 
substitution. 
 
The emission and excitation spectra obtained for the 6PdPc and 8PdPc 
compounds are similar and an example can be seen in Figure 6.3. The 
weak emission has maximum at 694 nm and maximum absorption at 
690 nm: a Stokes shift of 4 nm. This is similar to other substituted 
palladium phthalocyanines. 
 
Besides fluorescence emission, the degassed solutions of 6PdPc and 
8PdPc exhibit an additional emission in the near-infrared, Figure 6.3. 
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Figure 6. 3. Emission and excitation data of 6PdPc.
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Figure 6. 3. Absorption (solid line), fluorescence (dash, dot, dot) and phosphorescence spectra 
of 6PdPc and 8PdPc measured at room temperature, in 1% v/v toluene/pyridine. The 
absorption and fluorescence are normalized to an arbritrary maximum of 1.0. The 
fluorescence was obtained in air-saturated solution. The phosphorescence spectra were 
obtained with freeze-pump-thaw degassed samples and λex = 632 nm. 
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This peak vanishes upon reintroduction of oxygen to the system and is 
subsequently assigned to phosphorescence. In degassed 
toluene/pyridine the T1 (0,0) emission maxima are 1048 and 1052 nm 
for 6PdPc and 8PdPc compounds, respectively, at room temperature. 
These values compare well with previously published values of alpha 
octabutoxy PdPc which has a peak at 1107 nm.9 Both compounds are 
red-shifted compared with the parent compound that exhibits T1(0,0) 
emission band at 1007 nm.1 
 
Fluorescence lifetime decays could not be measured for these 
compounds due to the weak fluorescence and quantum yields 
determined were < 0.02. Such low fluorescence is a favourable 
property of photosensitizers used in PDT as it indicates that energy 
not lost via radiative pathways. The values are also typical of 
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Figure 6. 4. Transient triplet-triplet absorption spectrum of 6PdPc in 1% v/v 
pyridine/toluene, λex = 355 nm. The broad absorption with peak observed between 450 - 
620 nm is due to T – T* absorption.
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palladium phthalocyanines studied to date as the heavy-atom effect 
promotes spin-forbidden intersystem crossing. 
6.2.2 Photophysics 
The transient absorption spectra of both substituted palladium 
phthalocyanines are similar in shape with a broad peak between 450 – 
620 nm and maximum at 542 nm, Figure 6.4. Triplet decays were 
measured at this point by fitting an exponential. The triplet lifetimes 
were found to be 5 μs and 6 μs for 6PdPc and 8PdPc, respectively. 
These short lifetimes are typical of palladium phthalocyanines and are 
comparable to literature values of 25 μs for the unsubstituted parent 
compound, PdPc, and 3 μs for (OBu)8PdPc, which is within the 
expected range for phthalocyanines.1, 9 Triplet extinction coefficients 
were determined to be 1.0 and 1.2 x 104 M-1 cm-1 and using these 
values triplet quantum yields of 0.94 and 0.96 for 6PdPc and 8PdPc, 
respectively, were calculated. These values are close to unity and bode 
well for a potential photosensitizer, though the short triplet lifetimes 
are favourable, the high triplet quantum yields suggest minimal loss of 
energy through non-radiative pathways.  
6.2.3 Photochemistry 
Singlet delta oxygen, ΦΔ, values are the final property required to 
quantify the potential of any given compound as a photosensitizer for 
photodynamic therapy. Using time-resolved singlet oxygen 
phosphorescence detection, ΦΔ values of 0.92 and 0.93 for 6PdPc and 
8PdPc, respectively, were obtained. These values are close to unity 
and very promising in the search for efficient chemical 
photosensitizers. Furthermore, these compounds also have high SΔ 
values of 0.98 and 0.97 for 6PdPc and 8PdPc, respectively. This 
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coincides well with enhanced triplet state populations and the red-shift 
observed in the wavelength of phosphorescence.  
6.3 Conclusion 
To conclude, the substitution of long alkyl chains has a significant 
impact on the photophysical and photochemical properties of the 
palladium phthalocyanine molecule. This includes the 26 nm red-shift 
of the Q-band, facilitating deeper skin penetration, high triplet 
quantum yields, leading to the enhancement of the triplet state 
population, a red-shift of the triplet state, leading to high singlet 
oxygen quantum yields. Though there is no improvement in solubility 
within aqueous solvents and these molecules also have short triplet 
lifetimes, there is significant improvement of the photophysical and 
photochemical properties and the peripherally substituted compounds 
compare well with the analogous alpha-substituted palladium 
phthalocyanine compounds. 
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7. Discussion and Conclusion 
7.1 Variation of Central Metal Ion 
The aim of this work was to follow the effect of systematic changes to 
the phthalocyanine molecule on the photophysical and photochemical 
properties and evaluate these compounds as potential photosensitizers 
in photodynamic therapy. Three distinct families of phthalocyanines 
were studied containing either silicon hydroxide, zinc(II) or 
palladium(II) centres. Each has been reviewed relative to standards 
and parent compounds, where available, within their distinct group. 
However, the substitution of hexyl and octyl groups in the alpha 
position was applied in all three series and afforded a series of 
compounds identical in structure, but differing in metal ion centre. 
Tables 7.1 and 7.2 show the results collated across the groups.  
 
Compound λQ / nm εs / M-1cm-1 x 105 λf / nm τf / ns ΦF kf / 107s-1 
ZnPc1 671 2.8 676 3.1 0.34 11 
1ZnPc 694 2.5 704 2.5 0.16  
6ZnPc 704 1.8 718 1.8 0.12 6.67 
8ZnPc 704 1.8 718 1.8 0.12 6.67 
6ZnTBTAP 698, 674  703    
Si(OH)2Pc 692  702    
6Si(OH)2Pc 710 2.3 724 3.8 0.27 6.32 
8Si(OH)2Pc 710 2.3 724 3.8 0.27 6.32 
PdPc3 660  664    
6PdPc 688 0.67 - - - - 
8PdPc 688 0.67 - - - - 
Table 7. 1. Photophysical properties of the parent and alpha substituted phthalocyanine 
derivatives. 
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As has been previously discussed, there are a number of key points 
that must be taken into consideration upon optimisation of any 
compound as a photosensitizer. With the modifications applied to the 
basic phthalocyanine molecule it is possible to assess the advantages 
gained in each case. 
 
7.2 Amphiphilicity 
Hydrophobicity and hydrophilicity is key in the administration of 
photosensitisers due to the complex nature of cells and cell 
membranes.2 In all cases, it was observed that solubility in the 
pyridine-toluene mixture improved upon alkyl substitution. However, 
in the phthalocyanine derivatives studied the silicon series showed the 
greatest potential. This is due to the axial component of the molecule, 
which inhibits π-π stacking, the main source of aggregation. 
Compound τT / μs T-Tmax / nm Δε / 104 M-1cm-1 ΦT ΦΔ SΔ  ET / nm 
ZnPc 330 480 3.4 0.65 0.58 0.89 1092 (77K) 
1ZnPc 113  3.0 0.73 0.54 0.74  
6ZnPc 51 534 2.8 0.84 0.73 0.87  
8ZnPc 50 534 2.6 0.81 0.71 0.88  
6ZnTBTAP 380 520      
Si(OH)2Pc 103       
6Si(OH)2Pc 161 552 2.5 0.65 0.52 0.80  
8Si(OH)2Pc 196  4.6 0.72 0.50 0.70  
PdPc 25      1007 (300K) 
6PdPc 5   0.94 0.92 0.98 1048 (300K) 
8PdPc 6 542 0.4 0.96 0.93 0.97 1052 (300K) 
Table 7. 2. Triplet and photochemical properties of parent and alpha substituted 
phthalocyanines derivative. 
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Aggregation needs to be prevented as it leads to quenching, which 
significantly reduces the yield of the triplet state and therefore the 
efficiency of the compound as a photosensitiser.4 Furthermore, 
substitution of alkyl chains on the silicon phthalocyanines 
significantly improved solubility in aqueous media, and most 
importantly water. Though there are methods for combating a lack of 
solubility, including the introduction of phthalocyanines into 
liposomes and cyclodextrins, the administration of a single compound 
is considered to be important in the identification of a biological target. 
 
7.3 Red Absorption 
The importance of high molar extinction coefficients in the red, in 
particular the optical window of 600 – 850 nm, has been mentioned 
repeatedly as one of the keys to the success of PDT.5 One of the 
principal disadvantages associated with Photofrin® is low molar 
extinction coeffients, εs = 3000 cm-1 M-1 at 630 nm.6, 7 The low 
extinction coefficient and therapeutic wavelength limit the available 
treatment depth to millimetres and therefore restricts the overall 
benefit of this treatment over current methods. The Q-band maxima of 
all phthalocyanines studied have high extinction coefficients that fall 
well within the optical window, see Figure 7.1.8 It is clear to see that 
phthalocyanines exhibit a blue-shift upon increase in atomic number 
of the central metal ion, which is due to the stabilisation of the HOMO. 
However, a significant decrease in molar extinction coefficient with 
increase in atomic number of the central metal ion must also be noted. 
Addition of alpha-alkyl substituents, independent of chain length, 
induces a red-shift of the Q-band of approximately 20 – 30 nm in all 
cases. Consequently, such modifications show a significant 
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improvement in the potential penetration depth of PDT in comparison 
to current photosensitizers.9 
7.4 Fluorescence  
In an attempt to produce the most energetically efficient 
photosensitiser, low fluorescence is a desirable property. High 
fluorescence leads to energy loss directly from the singlet states rather 
than the excited molecule undergoing intersystem crossing to produce 
the triplet state. In the case of the phthalocyanines studied, 
fluorescence decreased significantly with increase in atomic number 
of the central metal ion and also upon alkyl-substitution, a clear 
indication of enhancement of spin-forbidden intersystem-crossing 
400 600 800 1000
0.01
0.1
1
10
100
 
 Hb(O2)
 Hb(H2O)
 H2O
A
bs
or
pt
io
n 
C
oe
ffi
ci
en
t/ 
a.
u
Wavelength/ nm
Optical window for PDT
600 650 700 750 800 850
0
2
4
6
8
10
12
14
16
18
20
22
24
26
28
30
E
xt
in
ct
io
n 
co
ef
fic
ie
nt
 / 
10
5  c
m
-1
 M
-1
Wavelength / nm
 6SiPc
 6ZnPc
 ZnPc
 6PdPc
 PdPc
 
 
Figure 7. 1. Illustration of the optical window as defined by a logarithmic plot of the 
absorption of key chromophores within a cell. Top right inset shows the relative 
absorption of hexyl-substituted silicon, zinc and palladium phthalocyanine derivatives 
and the parent compounds ZnPc and PdPc. 
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from the excited singlet state to the triplet state. However, there must 
also be some acknowledgement of the benefit of fluorescence such 
that, in the case of the substituted silicon phthalocyanines, with 
Φf = 0.27, the fluorescence can be utilised either as a diagnostic tool 
or as a means of determining optimum tumour saturation and so 
identify an optimum treatment time. Fluorescence of the 
photosensitiser also provides a means for measuring the rate of 
clearance of the drug from the system. Though, this is dependent on 
the metabolism of the compounds after administration and where the 
metabolites localise. 
7.5 Triplet Yields 
It is widely believed that the success of photodynamic therapy is due 
to the efficiency of triplet state formation by the photosensitisers and 
the lifetime of this state.10 With the phthalocyanines, the palladium 
analogues have high triplet quantum yields and favourable triplet 
energy, but very short triplet lifetimes and low triplet extinction 
coefficients. The success of photodynamic therapy depends on 
photosensitisers having triplet states with long lifetimes in order to 
form singlet delta oxygen from the molecular oxygen present in the 
cells. The drawbacks of such short-lived states are a loss of energy 
typically through triplet-triplet annihilation. Zinc and silicon 
phthalocyanines on the other hand exhibit lower triplet quantum than 
the palladium analogues as one might expect from a reduced heavy-
atom effect and therefore reduced spin-forbidden intersystem-crossing. 
In the case of the silicon phthalocyanines alpha-alkyl substitution also 
leads to an increase in triplet lifetimes. 
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7.6 Singlet Oxygen Quantum Yields 
Singlet oxygen quantum yields are the quantitative measure of the 
potential of any compound as a photosensitiser in in vitro conditions. 
It describes the efficiency of any given compound in the production of 
singlet delta oxygen, which is thought to be the destructive component 
of photodynamic therapy. The data indicates that singlet delta oxygen 
quantum yields increase with increasing heavy-atom effect and also 
with alpha-substitution of electron-donating groups. In fact, the 
pattern closely reflects the pattern of triplet state formation. If we look 
at the fraction of triplet states formed that lead to singlet delta oxygen 
states, SΔ, it can be seen that silicon and palladium phthalocyanines 
are the most efficient in vitro.  
7.7 Stability, Toxicity and Tumour Selectivity 
All of the parameters that have been evaluated for these 
phthalocyanines are a measure of the photochemistry and 
photophysics of the compounds. The following step in the 
determination of the validity of any one of these molecules as a future 
photosensitiser is to identify their stability in biological matter and 
whether any of these compounds exhibit tumour selectivity, before 
following up with clinical trials. Provisional cell kill data has 
previously been measured for the silicon and zinc phthalocyanine 
derivatives, which may suggest that the silicon derivatives are the 
more efficient photosensitisers.11 
7.8 Conclusion 
The phthalocyanine molecule has proved to be a compound with the 
potential for countless modifications.12 This study focused on the 
capacity to fine-tune the properties of phthalocyanines towards that of 
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an ideal photosensitiser. These included properties such as 
amphiphilicity, red absorption, low fluorescence, high triplet quantum 
yields and high singlet delta oxygen quantum yields. The benefits and 
drawbacks of each of the modifications have been discussed. In terms 
of the suitability of any one of the compounds studied and their 
potential as photosensitisers in photodynamic therapy a great 
emphasis has been put on the singlet delta oxygen quantum yields. It 
is observed that all phthalocyanine derivatives considered in this study 
have good ΦΔ, values typically greater than 0.5. However, there is a 
limit to the degree that this property can be improved. 
 
Foscan is a good example of a highly potent photosensitiser that has 
moderate quantum yields, ΦΔ = 0.4, absorbs at 660 nm and only 
requires low doses to achieve the same results as Photofrin®.13 The 
success of the photosensitiser is considered to be, in part, due 
enhanced penetration through tissue, increasing the available depth of 
treatment. With this in mind, it can be concluded that the alkyl-
substituted silicon phthalocyanine derivatives have the greatest 
potential as photosensitisers. These compounds, above all other 
phthalocyanine compounds considered in the study, exhibit the 
greatest red-shift in the Q-band maximum and have the highest molar 
extinction coefficients, with the exception of zinc phthalocyanine. The 
benefits of this include deeper penetration into tissue; hence lower 
light and photosensitiser doses. Coordination of the hydroxide ligands 
in the axial position affords greater solubility, due to a decrease in 
aggregation. Aggregation is largely brought about by π – π stacking in 
these systems.4 Solubility and amphiphilicity is a much sought after 
property in the field of photodynamic therapy as it aids the 
administration of the photosensitiser to the desired site through a 
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variety of aqueous and lipid cellular environments. Furthermore, 
solubility is further enhanced by the addition of alkyl substituents in 
the alpha position. In comparison with Photofrin® the photophysical 
and photochemical properties compare well and, as has previously 
been mentioned, cell kill data available in literature suggests that these 
silicon phthalocyanine derivatives are efficient photosensitisers.  
7.9 Future Work 
From the conclusions presented in this work it is clear that the silicon 
phthalocyanine derivatives make promising candidates for 
photosensitisers in photodynamic therapy and further work should be 
carried out to investigate how these compound function in biological 
environments. Two key properties to consider are selectivity and 
toxicity. It is essential to determine whether there is preferential 
absorption of these compounds by tumour cells over healthy cells and 
to ensure that the metabolism of the silicon phthalocyanines does not 
lead to harmful metabolites before moving forward with clinical trials. 
 
The work presented in this thesis has not only considered the 
phthalocyanine derivatives studied in this work, but also tried to put 
the data into context with previous studies conducted on 
phthalocyanines. It is believed that the data collected can be used to 
conduct theoretical studies on the implications of structural 
modifications on a molecular orbital level. Previous density functional 
theory studies have been conducted on zinc phthalocyanine,14, 15 and it 
is believed that such studies would enable one to be able to calculate 
the optimal modifications for the phthalocyanine molecule according 
to the desired properties. For example, it is known that one could 
enhance solubility using electron donating substituents or optimise 
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triplet properties with the insertion of heavy metal atoms, but a model 
may be able to give an indication of the extent of such actions. A 
concise model and associated database would also enhance the 
understanding of these molecules and their unique optical properties.
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